[go: up one dir, main page]

WO2022185819A1 - Skin cleaning agent composition - Google Patents

Skin cleaning agent composition Download PDF

Info

Publication number
WO2022185819A1
WO2022185819A1 PCT/JP2022/003997 JP2022003997W WO2022185819A1 WO 2022185819 A1 WO2022185819 A1 WO 2022185819A1 JP 2022003997 W JP2022003997 W JP 2022003997W WO 2022185819 A1 WO2022185819 A1 WO 2022185819A1
Authority
WO
WIPO (PCT)
Prior art keywords
mass
component
extract
particularly limited
appropriately selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2022/003997
Other languages
French (fr)
Japanese (ja)
Inventor
佐紀 續
愛里 平山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lion Corp
Original Assignee
Lion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corp filed Critical Lion Corp
Priority to KR1020237024696A priority Critical patent/KR20230149289A/en
Publication of WO2022185819A1 publication Critical patent/WO2022185819A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/02Anionic compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/02Anionic compounds
    • C11D1/04Carboxylic acids or salts thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/88Ampholytes; Electroneutral compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/88Ampholytes; Electroneutral compounds
    • C11D1/90Betaines
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2003Alcohols; Phenols
    • C11D3/2041Dihydric alcohols
    • C11D3/2048Dihydric alcohols branched
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2003Alcohols; Phenols
    • C11D3/2065Polyhydric alcohols
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/382Vegetable products, e.g. soya meal, wood flour, sawdust
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole
    • A61K2800/72Hypo-allergenic

Definitions

  • the present invention relates to a skin cleanser composition.
  • Skin cleansing compositions used for washing hands are required not only to have excellent foam quality, feel after washing, no irritation to hand skin, and stability, but also to have high bactericidal activity.
  • many synthetic chemical substances have been used as bactericidal components (see Patent Documents 1 and 2, for example).
  • the compounding conditions and compounding amounts of the synthetic chemical substances are generally determined from the viewpoint of safety and skin irritation.
  • indigenous bacteria that enhance the barrier function on the skin are also sterilized, there is a problem that repeated washing with a skin cleanser composition with a high sterilization effect causes rough and dry skin on the hands. rice field.
  • the extract obtained by the method of extracting with organic solvents such as alcohol which is a general extraction method of plants, and the method of extracting by acid treatment or alkali treatment, causes decomposition and aggregation of the active ingredients, color and Due to the generation of a peculiar offensive odor, there are restrictions on the conditions for blending in cosmetics such as skin cleansing compositions.
  • the plant extract has a low bactericidal power, and even if it is blended in a skin cleanser composition, there is a problem that the same bactericidal power as that of the synthetic chemical substance cannot be obtained.
  • the object of the present invention is to solve the above-mentioned problems in the past and to achieve the following objects. That is, the present invention maintains indigenous bacteria that enhance the barrier function on the skin, has high bactericidal activity against pathogenic E. coli, etc., has no coloration, has a good liquid appearance, and has an unpleasant odor. To provide a skin cleanser composition excellent in foam quality, feeling after cleansing, non-irritating hand skin, and stability.
  • the skin cleanser composition contains (A) an anionic surfactant, and (B) an extract selected from Sasa extract and mint water extract. and (C) at least one polyhydric alcohol selected from glycerin, 1,3-butylene glycol, and propylene glycol, and containing the component (B)
  • the mass ratio [(C)/(B)] of the content of the component (C) is set to the amount of 3 to 30, the indigenous bacteria that enhance the barrier function on the skin are maintained while maintaining pathogenicity.
  • the present invention is based on the findings of the present inventors, and means for solving the above problems are as follows. Namely ⁇ 1> (A) an anionic surfactant; (B) at least one plant extract selected from extracts of Sasa squamosa and water extracts of mint; (C) at least one polyhydric alcohol selected from glycerin, 1,3-butylene glycol, and propylene glycol; and wherein the mass ratio [(C)/(B)] of the content of component (C) to the content of component (B) is 3 to 30 be.
  • the content of component (A) is 5% by mass to 12% by mass
  • the content of the extract of component (B) is 0.5% by mass to 1.2% by mass
  • the content of the water extract of component (B) is 0.2% by mass to 0.2% by mass.
  • 5% by mass The skin cleanser composition according to any one of ⁇ 1> to ⁇ 2> above, wherein the component (C) is 5% by mass to 10% by mass.
  • a skin cleansing agent composition which is effective, has no coloration, good liquid appearance, no unpleasant odor, excellent foam quality, feel after cleansing, no irritation to hands and skin, and excellent stability. can.
  • the skin cleansing composition of the present invention comprises (A) an anionic surfactant, (B) at least one plant extract selected from extracts of S. japonica and water extracts of mint, (C) glycerin, 1,3-butylene glycol, and at least one polyhydric alcohol selected from propylene glycol, preferably further containing (D) an amphoteric surfactant, and if necessary, other Contains ingredients.
  • the anionic surfactant as the component (A) is mainly contained in order to improve foam quality, feeling after washing, and bactericidal activity against E. coli.
  • the anionic surfactant of component (A) is not particularly limited and can be appropriately selected depending on the intended purpose. Salts, amino acid-based surfactants and the like are included. These may be used individually by 1 type, and may use 2 or more types together. Among these, higher fatty acid salts are preferred from the viewpoints of foam quality, feel after washing, and bactericidal activity against Escherichia coli.
  • the higher fatty acid salt in the component (A) is not particularly limited and can be appropriately selected depending on the purpose. Examples include laurate, myristate, palmitate, stearate, etc. mentioned. These may be used individually by 1 type, and may use 2 or more types together. Among these, higher fatty acid salts containing both laurate and myristate are preferred.
  • the counter ion of the higher fatty acid salt is not particularly limited and can be appropriately selected depending on the intended purpose.
  • examples thereof include alkali metal salts, amine salts and amino acid salts.
  • the alkali metal salt is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include sodium salt and potassium salt.
  • the amine salt is not particularly limited and can be appropriately selected depending on the purpose. Examples include ammonium salt; monoethanolamine salt, diethanolamine salt, triethanolamine salt, and alkanolamine salts such as -amino-2-methylpropanediol.
  • the amino acid salt is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include lysine salts and arginine salts. Among these, alkali metal salts are preferred, and potassium salts are particularly preferred, from the viewpoint of excellent foam elasticity.
  • higher fatty acid salt an appropriately synthesized one may be used, or a commercially available product may be used.
  • Commercially available higher fatty acid salts include, for example, trade names of NIKKOL potassium laurate LK-120 (potassium laurate), NIKKOL potassium myristate MK-140 (potassium myristate), Thai Soap MNK-40 (coconut oil fatty acid), Potassium/potassium myristate mixed liquid (manufactured by Nikko Chemicals Co., Ltd.) and the like.
  • the higher fatty acid salt can be blended as a higher fatty acid salt, but the higher fatty acid and the counterion salt such as potassium hydroxide are separately added to a blending tank and neutralized. may be used as a higher fatty acid salt.
  • the higher fatty acid used for preparing the higher fatty acid salt may be appropriately synthesized or a commercially available product.
  • Commercially available higher fatty acids include, for example, NAA (registered trademark)-122 (lauric acid), NAA (registered trademark)-142 (myristic acid), and NAA (registered trademark)-160 (palmitic acid).
  • NAA (registered trademark)-180 (stearic acid) manufactured by NOF Corporation
  • Kortacid 1299 lauric acid
  • Kortacid 1499 myristic acid
  • the content of the laurate is not particularly limited and can be appropriately selected depending on the intended purpose. ⁇ 10% by mass is more preferred.
  • the content of the myristate salt is not particularly limited and can be appropriately selected depending on the intended purpose. % to 8% by mass is more preferred.
  • the content of the palmitate is not particularly limited and can be appropriately selected depending on the intended purpose. ⁇ 9% by mass is more preferred.
  • the content of the stearate is not particularly limited and can be appropriately selected depending on the purpose. .2% by mass to 1% by mass is more preferred.
  • the polyoxyethylene alkyl ether sulfate in the component (A) is not particularly limited and can be appropriately selected depending on the intended purpose.
  • the said polyoxyethylene alkyl ether sulfate may be used individually by 1 type, and may use 2 or more types together.
  • R 1 represents an alkyl group, and the alkyl group portion preferably has 10 to 14 carbon atoms.
  • n represents the average added mole number of ethylene oxide (E.O.), and the average added mole number of ethylene oxide is preferably 1 to 5.
  • X represents an alkali metal or ammonium.
  • the alkali metal is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include sodium and potassium.
  • polyoxyethylene alkyl ether sulfate examples include polyoxyethylene (1) sodium lauryl ether sulfate, polyoxyethylene (2) sodium lauryl ether sulfate (also known as POE (2) sodium laureth sulfate), polyoxyethylene (3) sodium lauryl ether sulfate (also known as POE (3) sodium laureth sulfate), polyoxyethylene (4) sodium lauryl ether sulfate, polyoxyethylene (5) sodium lauryl ether sulfate, polyoxyethylene (3) alkyl (C12 , 13) sodium ether sulfate, polyoxyethylene (2) ammonium lauryl ether sulfate, polyoxyethylene (3) ammonium lauryl ether sulfate, and the like.
  • the numerical value in said () represents the average addition mole number (n) of ethylene oxide (E.O.).
  • polyoxyethylene alkyl ether sulfate an appropriately synthesized one may be used, or a commercially available product may be used.
  • Commercially available polyoxyethylene alkyl ether sulfates include, for example, Emal 20C (polyoxyethylene (3) sodium lauryl ether sulfate), Emal 270J (polyoxyethylene (2) sodium lauryl ether sulfate), Emal 20CM (poly Oxyethylene (3) alkyl (C12,13) sodium ether sulfate), Emal 125HP (polyoxyethylene (1) sodium lauryl ether sulfate) (manufactured by Kao Corporation), Alscope (registered trademark) DA-330S (poly Oxyethylene (3) alkyl (C12,13) sodium ether sulfate), Alscope (registered trademark) A-225B (polyoxyethylene (2) ammonium lauryl ether sulfate) (manufactured by Toho Chemical Industry Co., Ltd.), Shin
  • the ether carboxylate in the component (A) is not particularly limited and can be appropriately selected depending on the intended purpose. is mentioned.
  • the ether carboxylates may be used singly or in combination of two or more.
  • R 2 is a linear or branched alkyl group or alkenyl group having 5 to 23 carbon atoms, or a linear or branched alkyl group or alkenyl group having 5 to 23 carbon atoms represents a phenyl group substituted with a group, and the number of carbon atoms in the R 2 moiety is preferably 10 to 14.
  • R 3 represents an alkylene group having 2 to 4 carbon atoms, and the number of carbon atoms in the R 3 moiety is preferably 2. Each R 3 may be the same or different.
  • o represents an average added mole number of 1 to 20 alkylene oxide, and the average added mole number of the alkylene oxide is preferably 1 to 5.
  • M1 represents a hydrogen atom, an alkali metal, an alkaline earth metal, ammonium, or a basic amino acid.
  • ether carboxylate represented by the general formula (A2) or (A3) include polyoxyethylene (3) sodium lauryl ether acetate, polyoxyethylene (4) potassium lauryl ether acetate, and sodium lauryl glycol acetate. etc.
  • the numerical value in said () represents the average added mole number (o) of alkylene oxide.
  • the ether carboxylate may be appropriately synthesized or may be a commercially available product.
  • Examples of commercially available ether carboxylates include Enagicol EC-30 (polyoxyethylene (3) sodium lauryl ether acetate, manufactured by Lion Specialty Chemicals Co., Ltd.), Beaulite LCA-25F (polyoxyethylene (3 ) Sodium lauryl ether acetate), Beaulite LCA-30D (polyoxyethylene (3) sodium lauryl ether acetate), Beaulite LCA-H (polyoxyethylene (4) lauryl ether acetic acid), Beaulite LCA-25NH (Laureth- 4 carboxylic acid), Beaulite SHAA (sodium lauryl glycol carboxylate), Beaulite LCA (polyoxyethylene (3) sodium lauryl ether acetate) (manufactured by Sanyo Chemical Industries, Ltd.), Kao Akipo RLM-45NV (polyoxyethylene (4.5) sodium lauryl ether acetate), Kaoakipo RLM-100NV (poly
  • amino acid-based surfactant in the component (A) is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include compounds represented by the following general formula (A4). .
  • the amino acid-based surfactants may be used singly or in combination of two or more.
  • R 4 is substituted with a linear or branched alkyl or alkenyl group having 5 to 23 carbon atoms, or a linear or branched alkyl or alkenyl group having 5 to 23 carbon atoms.
  • the number of carbon atoms in the R 4 moiety is preferably 8 to 18.
  • R 5 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms.
  • R 6 and R 7 represent a hydrogen atom or -(CH 2 ) m -COOM 2 . Said R6 and said R7 may be the same or different.
  • m and n represent numbers from 0 to 20. Said m and said n may be the same or different.
  • M 1 and M 2 represent a hydrogen atom, an alkali metal, an alkaline earth metal, ammonium, or a basic amino acid.
  • the M 1 and the M 2 may be the same or different.
  • the amino acid structure of the hydrophilic portion of the amino acid-based surfactant is not particularly limited and can be appropriately selected depending on the purpose, but glycine, glutamic acid, and methylalanine are preferred.
  • amino acid-based surfactant represented by the general formula (A4) include N-cocoyl-glycine potassium (N-coconut fatty acid acylglycine potassium), N-cocoyl-glycine sodium (N-coconut fatty acid N-acyl-glycine such as sodium acylglycinate) and salts thereof; N-acyl-N-carboxyethyl-glycine such as sodium N-myristoyl-N-carboxyethyl-glycine and salts thereof; sodium N-myristoyl-L-glutamate , N-lauroyl-L-sodium glutamate, potassium N-myristoyl-L-glutamate, potassium N-cocoate acyl-L-glutamate, N-cocoate acyl-L-sodium glutamate, N-palm acyl-L - N-acylglutamic acid and its salts such as sodium glutamate, sodium N-stearoyl-
  • amino acid-based surfactant an appropriately synthesized one may be used, or a commercially available product may be used.
  • Commercially available amino acid-based surfactants include, for example, trade names of Amylite (registered trademark) GCK-11 (potassium N-coconut oil fatty acid acylglycine) and Amylite (registered trademark) GCK-12K (N-coconut oil Potassium fatty acid acylglycinate), Amylite (registered trademark) GCS-12K (sodium N-coconut acylglycinate), Amylite (registered trademark) GCS-11 (sodium N-coconut acylglycinate), Amisoft (registered trademark) CS -11 (N-myristoyl-L-sodium glutamate), Amisoft (registered trademark) CS-22 (N-coconut fatty acid acyl-L-glutamate sodium), Amisoft (registered trademark) LS-11 (N-lauroyl-L-
  • the content of the anionic surfactant of component (A) is not particularly limited and can be appropriately selected according to the purpose. , preferably 3% by mass to 14% by mass, more preferably 5% by mass to 12% by mass, based on the total amount of the skin cleanser composition.
  • the content of component (A) is 3% by mass or more, the foam quality, feeling after washing, and bactericidal activity against E. coli are good, and when it is 14% by mass or less, stability, particularly low temperature stability, is obtained. Good properties.
  • the plant extract as the component (B) is at least one selected from extracts of Sasa chinensis and water extract oil of mint, and is mainly contained in order to improve bactericidal activity against Escherichia coli.
  • Sasa extract - Sasa kurilensis used as a raw material for the Sasa kurilensis extract is a monocotyledonous plant belonging to the genus Sasa , Bambusoidea , Poaceae . It is widely grown or cultivated in Japan and is easily available.
  • the bamboo grass used as the raw material for extraction may be a variety of bamboo grass.
  • Variants of the above-mentioned Chishimazasa are not particularly limited as long as the effect of the present invention is exhibited, and can be appropriately selected according to the purpose. Examples include konshimachishima, chabomakiba, chaboshimofurichishima, horrizaekifunemagari, makibanemagari, miirochishima, variant ezonemagari, and nagabanemagaridake. These may be used individually by 1 type, and may use 2 or more types together. In the present specification, Sasa serrata and its variants are collectively referred to as ⁇ Sasa family''.
  • the extract of the above-mentioned Sasa spp There is no particular limitation on the method of obtaining the above-mentioned Sasa spp., it can be appropriately selected according to the purpose, and it may be collected from the natural world or commercially available.
  • the Sasa extract can be easily obtained by a method generally used for extracting plants, but it is extracted by an extraction method such as a steam distillation method or a compression extraction method in terms of bactericidal activity against Escherichia coli and liquid appearance. is preferred, and a purified product of the extract is more preferred. These extraction methods may be performed singly or in combination of two or more.
  • the use part of the Sasa spp. used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose.
  • above-ground parts such as branches and leaves; underground parts such as roots and rhizomes. These may be used individually by 1 type, and may use 2 or more types together. Among these, the above-ground part is preferable as the part to be used of the above-mentioned Sasa.
  • the size of the bamboo grass used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. ) and the like.
  • the state of the bamboo grass used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose.
  • the method for drying the bamboo grass used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. and a method of drying using
  • the method for pulverizing the bamboo grass used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. Examples include a method of pulverizing with a pulverizer or the like.
  • the water used as the extraction solvent is not particularly limited and can be appropriately selected according to the purpose.
  • the amount of the extraction solvent used is not particularly limited, and can be appropriately selected according to the purpose.
  • the extraction conditions for the extract of S. magnolia are not particularly limited, and can be appropriately selected from known methods according to the purpose.
  • the compression extraction method is preferably carried out at a low temperature and a high pressure. Generally, the extraction temperature is 70° C. or less and the pressure is reduced from 100 mmHg to 700 mmHg.
  • the state of the Sasa serrata extract is not particularly limited, and can be appropriately selected according to the purpose. It may be a concentrate of the extract, a diluted product of the extract, a dried product of the extract of the bamboo grass, or the like. In addition, the extract of Sasa serrata may be obtained by mixing or dissolving the dried Sasa extract again in water.
  • Sasa serrata water obtained by extracting and purifying Sasa serrata by low-temperature and high-pressure extraction is preferable to use Sasa serrata water obtained by extracting and purifying Sasa serrata by low-temperature and high-pressure extraction.
  • Commercially available products of such Sasa extract include, for example, Aqua Aroma Kumazasa (manufactured by Arista Health and Nutrition Science Co., Ltd.) and Sasa Sasa Water K2-C (manufactured by Nihon Haruma Co., Ltd.).
  • the content of the extract of Sasa chinensis is not particularly limited and can be appropriately selected according to the purpose. % to 1.5% by mass, more preferably 0.5% to 1.2% by mass. When the content of the Sasa extract is 0.5% by mass or more or 1.5% by mass or less, the bactericidal activity against Escherichia coli is good.
  • Mint water extract The mint used as a raw material for the aqueous mint extract is a plant belonging to the genus Mentha in the family Lamiaceae , and most of the species are perennials, but some species are annuals. It is widely grown or cultivated in Japan and is easily available.
  • the plant belonging to the genus Mentha is not particularly limited and can be appropriately selected depending on the intended purpose. mentioned. These may be used individually by 1 type, and may use 2 or more types together. Among these, Japanese mint and yellow mint are preferable.
  • the method for obtaining the plant belonging to the Mentha genus is not particularly limited, and can be appropriately selected depending on the intended purpose.
  • the water extract of mint can be easily obtained by a method commonly used for extracting plants, but an extract extracted and purified by a steam distillation method is preferable in terms of bactericidal activity against Escherichia coli and liquid appearance. .
  • the used part of the plant belonging to the genus Mentha used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose.
  • Aerial parts such as leaves, branches, branches and leaves; and underground parts such as roots and rhizomes. These may be used individually by 1 type, and may use 2 or more types together. Among these, the above-ground part is preferable as the used part of the plant belonging to the genus Mentha.
  • the size of the plant belonging to the genus Mentha used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. Examples thereof include a size in which fine powder is formed.
  • the state of the plant belonging to the genus Mentha used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose.
  • the state of the juice etc. are mentioned.
  • the method for drying the plant belonging to the genus Mentha used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. and a method of drying using a drier.
  • the method for pulverizing the plant belonging to the genus Mentha used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. , a method of pulverizing with an impact pulverizer or the like.
  • the method for squeezing the plant belonging to the genus Mentha used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. Examples include pressing.
  • the water used as an extraction solvent for the mint water extract is not particularly limited and can be appropriately selected according to the purpose.
  • the amount of the extraction solvent used is not particularly limited, and can be appropriately selected according to the purpose.
  • the extraction conditions (atmospheric conditions such as extraction time, extraction temperature, pressure, etc.) for the water extract of mint are not particularly limited, and can be appropriately selected from known methods according to the purpose.
  • the state of the mint water extract is not particularly limited and can be appropriately selected according to the purpose. It may be a purified product or a purified product, a concentrate of the mint aqueous extract, a diluted mint aqueous extract, a dried mint aqueous extract, or the like.
  • the mint water extract may be obtained by remixing or dissolving the dried mint water extract in water.
  • the water extract of mint is preferably mint oil obtained by extracting and refining a plant belonging to the genus Mentha by steam distillation.
  • Commercially available products of such a water extract of mint include, for example, mint oil (manufactured by Suzuki Mint Co., Ltd.) and peppermint white oil (manufactured by Nagaoka Jitsugyo Co., Ltd.).
  • the content of the mint water extract is not particularly limited and can be appropriately selected according to the intended purpose. 0.1% by mass to 0.6% by mass is preferable, and 0.2% by mass to 0.5% by mass is more preferable.
  • the content of the mint aqueous extract is 0.1% by mass or more, the bactericidal activity against Escherichia coli is good, and when it is 0.6% by mass or less, a specific odor can be suppressed. .
  • the polyhydric alcohol as the component (C) is mainly contained to improve the foam quality and feel after cleansing.
  • the polyhydric alcohol of component (C) is at least one selected from glycerin, 1,3-butylene glycol, and propylene glycol.
  • the polyhydric alcohol of component (C) an appropriately synthesized one may be used, or a commercially available product may be used.
  • Commercially available products of glycerin as the polyhydric alcohol of component (C) include, for example, ELOGLYN R995 (glycerin) (manufactured by LG Household & Health Care), concentrated glycerin for cosmetics (manufactured by Miyoshi Oil Co., Ltd.), Triol VE (manufactured by KOKYU ALCOHOL KOGYO Co., Ltd.) and the like.
  • 1,3-butylene glycol as the polyhydric alcohol of component (C)
  • Commercially available products of 1,3-butylene glycol as the polyhydric alcohol of component (C) include, for example, High Sugar Cane BG (manufactured by Kokyu Alcohol Kogyo Co., Ltd.) under the trade name.
  • propylene glycol as the polyhydric alcohol of component (C)
  • Commercial products of propylene glycol as the polyhydric alcohol of component (C) include, for example, cosmetic propylene glycol (manufactured by ADEKA) and Propylene Glycol JSQI (manufactured by Dow Chemical).
  • the content of the polyhydric alcohol of component (C) is not particularly limited and can be appropriately selected according to the purpose. 3% by mass to 12% by mass, more preferably 5% by mass to 10% by mass. When the content of component (C) is 3% by mass or more, the foam quality and feel after washing are good, and when it is 12% by mass or less, the foam quality and feel after washing are good.
  • the mass ratio [(C)/(B)] of the content (% by mass) of the component (C) to the content (% by mass) of the component (B) has a high bactericidal activity against Escherichia coli and Staphylococcus epidermidis It is 3 to 30, preferably 5 to 25, because of its low bactericidal activity against (indigenous skin bacteria).
  • the mass ratio [(C)/(B)] is less than 3 or more than 30, the bactericidal activity against E. coli is lowered.
  • amphoteric surfactant as component (D) is mainly contained to improve foam quality.
  • amphoteric surfactant is not particularly limited and can be appropriately selected depending on the intended purpose. Hydroxysulfobetaine type amphoteric surfactants, amidosulfobetaine type amphoteric surfactants, phosphobetaine type amphoteric surfactants, imidazoline type amphoteric surfactants, amine oxide type amphoteric surfactants and the like. These may be used individually by 1 type, and may use 2 or more types together.
  • the alkylbetaine-type amphoteric surfactant is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include betaine lauryldimethylaminoacetate and laurylbetaine. These may be used individually by 1 type, and may use 2 or more types together.
  • amidobetaine-type amphoteric surfactant is not particularly limited and can be appropriately selected depending on the intended purpose.
  • betaine coconut oil fatty acid amidopropyl betaine
  • These may be used individually by 1 type, and may use 2 or more types together.
  • the sulfobetaine-type amphoteric surfactant is not particularly limited and can be appropriately selected according to the purpose. Examples thereof include coconut oil fatty acid dimethylsulfopropylbetaine. These may be used individually by 1 type, and may use 2 or more types together.
  • the hydroxysulfobetaine-type amphoteric surfactant is not particularly limited and can be appropriately selected depending on the purpose. Examples include lauryl hydroxysultaine. These may be used individually by 1 type, and may use 2 or more types together.
  • amidosulfobetaine-type amphoteric surfactant is not particularly limited and can be appropriately selected according to the purpose. Examples thereof include cocamidopropyl hydroxysultaine and lauramidopropyl hydroxysultaine. These may be used individually by 1 type, and may use 2 or more types together.
  • the phosphobetaine-type amphoteric surfactant is not particularly limited and can be appropriately selected depending on the purpose. Examples include lauryl hydroxyphosphobetaine. These may be used individually by 1 type, and may use 2 or more types together.
  • the imidazoline type amphoteric surfactant is not particularly limited and can be appropriately selected depending on the intended purpose. and N-hydroxyethylimidazolinium betaine. These may be used individually by 1 type, and may use 2 or more types together.
  • the amine oxide type amphoteric surfactant is not particularly limited and can be appropriately selected according to the purpose. Examples thereof include lauryl dimethylamine oxide and coconut oil alkyldimethylamine oxide. These may be used individually by 1 type, and may use 2 or more types together.
  • amphoteric surfactant of component (D) may be appropriately synthesized or commercially available.
  • commercially available amphoteric surfactants of component (D) include NIKKOL AM-3130N (cocamidopropyl betaine, manufactured by Nikko Chemicals Co., Ltd.), TEGO Betain (cocamidopropyl betaine, manufactured by Evonik), and the like.
  • Amphitol 20AB (lauryl amide propyl betaine, manufactured by Kao Corporation), MITAINE L (lauryl betaine, manufactured by Miwon Commercial), Ampholex LSB (lauryl hydroxysultaine, Miyoshi Oil Co., Ltd.), Amphithol 20HD (lauryl hydroxysultaine Tyne, manufactured by Kao Corporation), Softazoline LSB (lauramidopropyl hydroxysultaine, Kawaken Fine Chemicals Co., Ltd.), Softazoline CH (2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, Kawaken Fine Chemicals Co., Ltd.) company), Amphitol 20N (lauryl dimethylamine oxide, manufactured by Kao Corporation), Unisafe (registered trademark) A-LM (lauryl dimethylamine oxide, manufactured by NOF Corporation), and the like.
  • the content of the amphoteric surfactant as component (D) is not particularly limited and can be appropriately selected according to the purpose. It is preferably 0.1% by mass to 5% by mass, more preferably 0.5% by mass to 4% by mass, based on the total amount of the agent composition. When the content of the component (D) is 0.1% by mass or more, the foam quality is good, and when it is 5% by mass or less, the hand skin is not irritated.
  • the other components are not particularly limited and can be appropriately selected depending on the intended purpose. Examples include silicones, moisturizing agents, anionic surfactants other than the component (A) sodium ether sulfate, etc.), nonionic surfactants (e.g., polyoxyethylene alkyl ethers, etc.), cationic surfactants (e.g., stearyltrimethylammonium chloride, etc.), anti-inflammatory agents (e.g., dipotassium glycyrrhizinate, glycyrrhetinic acid, allantoin, etc.), vitamins, cationic polymers (e.g., cationized cellulose, cationized guar gum, polydimethyldimethylethylenepyrrolidinium chloride (polyquaternium-6), dimethyldiallylammonium chloride/acrylamide copolymer, etc.), amphoteric polymers ( acrylic acid/dimethyldiallylammonium copolymer, etc.), anionic poly
  • fragrances e.g., methylparaben, phenoxyethanol, etc.
  • sugars oils, lanolin derivatives, protein derivatives, acrylic resins Dispersion liquid, antioxidant, sequestering agent, ultraviolet absorber, wetting agent (e.g., sorbitol, etc.), emulsifier (e.g., steareth-11, trideceth-8, octyldodeceth-5, etc.), chelating agent (e.g., EDTA-4Na etc.), pH adjusters (eg, potassium hydroxide, monoethanolamine, etc.), solvents (eg, water, etc.), and the like.
  • wetting agent e.g., sorbitol, etc.
  • emulsifier e.g., steareth-11, trideceth-8, octyldodeceth-5, etc.
  • chelating agent e.g., EDTA-4Na etc.
  • pH adjusters eg
  • the pH of the skin cleanser composition at 25° C. is not particularly limited and can be appropriately selected depending on the intended purpose. preferable.
  • the pH can be measured, for example, using a pH meter (HM-30V manufactured by Toa DKK Co., Ltd.).
  • the skin cleanser composition of the present invention is not particularly limited, and is used by being filled in a normal container.
  • the container is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include a pump dispenser container, a tube container, a foamer container, a squeeze container, and a bag-like container. Among these, a former container is preferable.
  • the foamer container is not particularly limited and can be appropriately selected from known foamer containers. Examples thereof include a non-gas type foam discharge container, an aerosol container using a propellant and a pressure container, and the like. Among these, a non-gas foam discharge container is preferable.
  • the non-gas type foam discharge container is not particularly limited as long as it can mix the skin cleanser composition with air and discharge it in a foamed state, and can be appropriately selected according to the purpose.
  • a squeeze foamer container capable of discharging foam by squeezing the body of the bottle by hand, and a pump foaming container capable of discharging foam by pushing down the nozzle portion may be used.
  • a former container those manufactured by Yamato Seikan Co., Ltd., Yoshino Kogyosho Co., Ltd., or the like can be used. More specifically, as the former container, the former containers described in JP-A-7-315463, JP-A-8-230961, and JP-A-2005-193972 can be used.
  • the non-gas type foam dispenser usually has a foam forming member for forming foam.
  • a specific example of the non-gas type foam discharge container has a porous membrane (preferably made of a plastic material such as nylon, polyester, or polyolefin), and the skin cleanser composition is applied to the porous membrane. Examples include those that form bubbles upon passage.
  • the mesh of the porous membrane is not particularly limited and can be appropriately selected depending on the purpose.
  • the number of the porous membranes is not particularly limited and can be appropriately selected depending on the purpose, but from the viewpoint of improving foam performance, 2 to 4 are preferable.
  • the properties of the skin cleanser composition are not particularly limited and can be appropriately selected depending on the intended purpose, but liquid form at room temperature is preferable.
  • the viscosity of the skin cleanser composition at 25° C. is not particularly limited and can be appropriately selected depending on the intended purpose. preferable.
  • Foam quality is favorable in the said viscosity being 1 mPa*s or more or 30 mPa*s or less.
  • a foamer container for example, when using a pump foamer container that can discharge foam by pushing down the nozzle part and two 200-mesh porous membranes, the skin is washed under the temperature conditions used.
  • the viscosity of the agent composition is preferably 15 mPa ⁇ s or less, more preferably 1 mPa ⁇ s to 10 mPa ⁇ s.
  • the viscosity is determined, for example, by using a Brookfield viscometer, setting the temperature of the skin cleanser composition to 25° C., rotating at 60 rotations/minute, No. It can be measured by measuring the viscosity after 1 minute with No. 1 rotor.
  • the method for producing the skin cleanser composition of the present invention is not particularly limited and can be appropriately selected according to the purpose. It can be obtained by mixing the component (D), optionally the other components, and the purified water (blended as the remaining amount so that the entire skin cleanser composition is 100% by mass). . When mixing, you may heat as needed.
  • the skin cleanser composition may be prepared using an apparatus.
  • the device is not particularly limited and can be appropriately selected depending on the intended purpose.
  • the stirring blade is not particularly limited and can be appropriately selected depending on the purpose. Examples thereof include propellers, turbines, and dispersers.
  • the application site of the skin cleanser composition is not particularly limited and can be appropriately selected according to the intended purpose.
  • the method of using the skin cleanser composition is not particularly limited and can be appropriately selected according to the intended purpose.
  • the skin cleanser composition retains the indigenous bacteria that enhance the barrier function on the skin, has high bactericidal activity against pathogenic E. coli and the like, and has a good liquid appearance without coloration. It has no unpleasant odor, excellent foam quality, feel after washing, no irritation to hands and skin, and excellent stability. It can be used for makeup removal and the like, and can be particularly suitably used for liquid hand soap that is discharged in foam form.
  • the component (B) "mint oil” is an extract obtained by a steam distillation extraction method
  • the component (B) “Chishima Sasa water” is an extract obtained by a compression extraction method.
  • the comparative component of component (B) is a solvent extract using butylene glycol or ethanol as an extraction solvent.
  • ⁇ Bactericidal power against E. coli> Preparation of bacterial solution A representative Escherichia coli that causes infectious diseases ( Escherichia coli NBRC3972: Gram-negative bacteria, obtained from the National Institute of Technology and Evaluation) was prepared using SCDLP medium (manufactured by Nihon Pharmaceutical Co., Ltd.). Static culture was carried out at 30° C. for 24 hours under aerobic conditions. Next, the Escherichia coli was suspended in physiological saline (manufactured by Otsuka Pharmaceutical Co., Ltd.), and the number of initial bacteria was adjusted to 10 6 cells/mL to prepare a bacterial solution.
  • SCDLP medium manufactured by Nihon Pharmaceutical Co., Ltd.
  • Static culture was carried out at 30° C. for 24 hours under aerobic conditions.
  • the Escherichia coli was suspended in physiological saline (manufactured by Otsuka Pharmaceutical Co., Ltd.), and the number of initial bacteria was adjusted to 10 6 cells/m
  • Sterilization number ⁇ log 10 -log 10 (number of surviving bacteria/number of initial bacteria) Formula (1) -Judgment criteria for “Bactericidal activity against Escherichia coli”- ⁇ : ⁇ log 10 is 2.7 or more ⁇ : ⁇ log 10 is 2.5 or more and less than 2.7 ⁇ : ⁇ log 10 is 2.0 or more and less than 2.5 ⁇ : ⁇ log 10 is less than 2.0
  • the total score of the average evaluation points of (1) to (3) is 12.0 points or more, and the average evaluation score of all items (1) to (3) is 4 points or more ⁇ : (1) to (3) ) has a total score of 9.0 or more and less than 12.0 points, and the average score of all items (1) to (3) is 3 points or more ⁇ : Average of (1) to (3) The total evaluation score is 6.0 or more and less than 9.0 points, and the average evaluation score of all items (1) to (3) is 2 points or more ⁇ : Average evaluation of (1) to (3) The total score is less than 6.0 points
  • Each skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 12 was filled in a foamer container (manufactured by Yoshino Kogyosho Co., Ltd.).
  • Three expert panels evaluated (1) "refreshing feeling after rinsing” and (2) "moist feeling after rinsing" of each of the skin cleanser compositions of Examples 1 to 32 and Comparative Examples 1 to 12 filled in the container. ”Evaluated by the following method, calculated the average score of the three specialized panels for each item, calculated the total score of the average scores of (1) and (2), and calculated the total score of the average scores of (1) and (2), Afterward feeling” was judged.
  • the total score of the average evaluation points of (1) and (2) is 8.0 points or more ⁇ : The total score of the average evaluation points of (1) and (2) is 7.0 points or more and less than 8.0 points ⁇ : The total score of the average evaluation points of (1) and (2) is 5.0 points or more and less than 7.0 points ⁇ : The total score of the average evaluation points of (1) and (2) is less than 5.0 points
  • Each skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 12 was filled in a foamer container (manufactured by Yoshino Kogyosho Co., Ltd.). Three expert panelists wet both hands with water and shake them once to lightly dry them. It was discharged from the former container under the condition of 25°C. Rub the palms of both hands in a reciprocating motion, rub the palms together for 10 seconds, rinse both hands with tap water (25 ° C, 2 L / min), dry with a towel, ” was evaluated based on the following evaluation criteria. The results were evaluated based on the following evaluation criteria by calculating the average score of 3 expert panelists.
  • the total score of (1) to (3) is 12.0 points or more, and all items (1) to (3) are 3 points or more ⁇ : The total score of (1) to (3) is 9.0 points points or more and less than 12.0 points, and all items (1) to (3) are 3 points or more ⁇ : The total points of (1) to (3) are 6.0 points or more and less than 9.0 points, and (1 ) to (3) all items are 2 points or more ⁇ : Total score of (1) to (3) is less than 6.0 points
  • the skin cleanser composition preferably has low bactericidal activity against Staphylococcus epidermidis. Therefore, the bactericidal activity against Staphylococcus epidermidis of each of the skin cleansing compositions of Examples 1 to 32 was evaluated by the following method.
  • Staphylococcus epidermidis Staphylococcus epidermidis ATCC12228, obtained from the National Institute of Technology and Evaluation (NBRC)
  • SCDLP medium manufactured by Nihon Pharmaceutical Co., Ltd.
  • SCDLP medium manufactured by Nihon Pharmaceutical Co., Ltd.
  • the above-mentioned Staphylococcus epidermidis was suspended in physiological saline (manufactured by Otsuka Pharmaceutical Co., Ltd.), and the number of initial bacteria was adjusted to 10 6 cells/mL to prepare a bacterial solution.
  • Sterilization number ⁇ log 10 -log 10 (number of surviving bacteria/number of initial bacteria) Equation (2) - Criteria for "Bactericidal activity against Staphylococcus epidermidis" - ⁇ : ⁇ log 10 is less than 1.0 ⁇ : ⁇ log 10 is 1.0 or more and less than 2.0 ⁇ : ⁇ log 10 is 2.0 or more and less than 3.0 ⁇ : ⁇ log 10 is 3.0 or more
  • Potassium laurate was prepared by neutralizing lauric acid (Kortacid 1299, manufactured by Pacific Oleochemicals) with potassium hydroxide (POTASSIUM HYDROXIDE 48%, manufactured by UNID).
  • Potassium myristate was prepared by neutralizing myristic acid (Kortacid 1499, manufactured by Pacific Oleochemicals) with potassium hydroxide (POTASSIUM HYDROXIDE 48%, manufactured by UNID).
  • the skin cleanser composition retains the indigenous bacteria that enhance the barrier function on the skin, has high bactericidal activity against pathogenic E. coli and the like, and has a good liquid appearance without coloration. It has no unpleasant odor, excellent foam quality, feel after washing, no irritation to hands and skin, and excellent stability. It can be used for makeup removal and the like, and can be particularly suitably used for liquid hand soap that is discharged in foam form.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

A skin cleaning agent composition containing (A) an anionic surfactant, (B) at least one plant extract selected from among an extract of Sasa kurilensis and a water extract of mint, and (C) at least one polyhydric alcohol selected from among glycerin, 1,3-butylene glycol, and propylene glycol, wherein the mass ratio [(C)/(B)] of the content amount of the ingredient (C) relative to the content amount of the ingredient (B) is 3-30.

Description

皮膚洗浄剤組成物skin cleanser composition

 本発明は、皮膚洗浄剤組成物に関する。 The present invention relates to a skin cleanser composition.

 手指の洗浄に用いる皮膚洗浄剤組成物には、泡質、洗浄後の感触、手肌への刺激のなさ、及び安定性に優れるだけでなく、高い殺菌力を有することが求められており、従来、殺菌成分として合成化学物質が多く使われてきた(例えば、特許文献1及び2参照)。しかし、前記合成化学物質は、一般的に安全性や皮膚刺激の点から、配合条件や配合量が定められている。また、皮膚上のバリア機能を高める常在菌をも殺菌してしまうため、殺菌効果の高い皮膚洗浄剤組成物を用いて洗浄を繰り返すことにより、手肌の荒れや乾燥を引き起こすという課題があった。 Skin cleansing compositions used for washing hands are required not only to have excellent foam quality, feel after washing, no irritation to hand skin, and stability, but also to have high bactericidal activity. Conventionally, many synthetic chemical substances have been used as bactericidal components (see Patent Documents 1 and 2, for example). However, the compounding conditions and compounding amounts of the synthetic chemical substances are generally determined from the viewpoint of safety and skin irritation. In addition, since indigenous bacteria that enhance the barrier function on the skin are also sterilized, there is a problem that repeated washing with a skin cleanser composition with a high sterilization effect causes rough and dry skin on the hands. rice field.

 そこで、植物由来の手肌に優しい抗菌成分が求められている。しかし、植物の一般的な抽出方法であるアルコール等の有機溶剤によって抽出する方法、及び酸処理又はアルカリ処理によって抽出する方法によって得られた抽出物は、有効成分の分解や凝集が起こり、着色や特有の嫌味臭が発生するため、皮膚洗浄剤組成物等の化粧品への配合条件に制限があった。また、前記植物抽出物は、殺菌力が低く、皮膚洗浄剤組成物に配合しても、前記合成化学物質と同等の殺菌力が得られないという課題があった。 Therefore, plant-derived antibacterial ingredients that are gentle on the skin of the hands are in demand. However, the extract obtained by the method of extracting with organic solvents such as alcohol, which is a general extraction method of plants, and the method of extracting by acid treatment or alkali treatment, causes decomposition and aggregation of the active ingredients, color and Due to the generation of a peculiar offensive odor, there are restrictions on the conditions for blending in cosmetics such as skin cleansing compositions. In addition, the plant extract has a low bactericidal power, and even if it is blended in a skin cleanser composition, there is a problem that the same bactericidal power as that of the synthetic chemical substance cannot be obtained.

 したがって、皮膚上のバリア機能を高める常在菌は保持しながら、病原性を持つ大腸菌等に対しては高い殺菌力を有し、着色がなく液外観が良好であり、嫌味臭がなく、泡質、洗浄後の感触、手肌への刺激のなさ、及び安定性に優れる皮膚洗浄剤組成の提供が強く望まれている。 Therefore, while maintaining the indigenous bacteria that enhance the barrier function on the skin, it has high sterilization power against pathogenic E. coli, etc., has no coloration, has a good appearance, has no unpleasant odor, and foams. It would be highly desirable to provide a skin cleanser composition that is superior in quality, feel after cleansing, non-irritation to the hands, and stability.

国際公開第2011/043226号WO2011/043226 特開2006-182698号公報Japanese Patent Application Laid-Open No. 2006-182698

 本発明は、従来における前記諸問題を解決し、以下の目的を達成することを課題とする。即ち、本発明は、皮膚上のバリア機能を高める常在菌は保持しながら、病原性を持つ大腸菌等に対しては高い殺菌力を有し、着色がなく液外観が良好であり、嫌味臭がなく、泡質、洗浄後の感触、手肌への刺激のなさ、及び安定性に優れる皮膚洗浄剤組成を提供することを目的とする。 The object of the present invention is to solve the above-mentioned problems in the past and to achieve the following objects. That is, the present invention maintains indigenous bacteria that enhance the barrier function on the skin, has high bactericidal activity against pathogenic E. coli, etc., has no coloration, has a good liquid appearance, and has an unpleasant odor. To provide a skin cleanser composition excellent in foam quality, feeling after cleansing, non-irritating hand skin, and stability.

 本発明者らは、前記目的を達成すべく鋭意検討を行った結果、皮膚洗浄剤組成物において、(A)アニオン性界面活性剤と、(B)チシマザサ抽出物及びハッカの水抽出物から選択される少なくとも1種の植物抽出物と、(C)グリセリン、1,3-ブチレングリコール、及びプロピレングリコールから選択される少なくとも1種の多価アルコールと、を含有し、前記(B)成分の含有量に対する前記(C)成分の含有量の質量比[(C)/(B)]を3~30とすることにより、皮膚上のバリア機能を高める常在菌は保持しながら、病原性を持つ大腸菌等に対しては高い殺菌力を有し、着色がなく液外観が良好であり、嫌味臭がなく、泡質、洗浄後の感触、手肌への刺激のなさ、及び安定性に優れることを知見した。 The inventors of the present invention have conducted intensive studies to achieve the above object, and found that the skin cleanser composition contains (A) an anionic surfactant, and (B) an extract selected from Sasa extract and mint water extract. and (C) at least one polyhydric alcohol selected from glycerin, 1,3-butylene glycol, and propylene glycol, and containing the component (B) By setting the mass ratio [(C)/(B)] of the content of the component (C) to the amount of 3 to 30, the indigenous bacteria that enhance the barrier function on the skin are maintained while maintaining pathogenicity. It should have high bactericidal activity against Escherichia coli, etc., should have good liquid appearance without discoloration, should have no offensive odor, and should have excellent foam quality, feel after washing, no irritation to hands and skin, and stability. I found out.

 本発明は、本発明者らによる前記知見に基づくものであり、前記課題を解決するための手段としては以下の通りである。即ち、
 <1> (A)アニオン性界面活性剤と、
 (B)チシマザサ抽出物及びハッカの水抽出物から選択される少なくとも1種の植物抽出物と、
 (C)グリセリン、1,3-ブチレングリコール、及びプロピレングリコールから選択される少なくとも1種の多価アルコールと、
を含有し、前記(B)成分の含有量に対する前記(C)成分の含有量の質量比[(C)/(B)]が3~30であることを特徴とする皮膚洗浄剤組成物である。
 <2> (B)成分のチシマザサ抽出物がチシマザサ水であり、(B)成分のハッカの水抽出物がハッカ油である前記<1>に記載の皮膚洗浄剤組成物である。
 <3> (A)成分の含有量が、5質量%~12質量%であり、
 (B)成分のチシマザサ抽出物の含有量が、0.5質量%~1.2質量%であり、(B)成分のハッカの水抽出物の含有量が、0.2質量%~0.5質量%であり、
 (C)成分が、5質量%~10質量%である前記<1>から<2>のいずれかに記載の皮膚洗浄剤組成物である。
 <4> (D)両性界面活性剤を更に含有する前記<1>から<3>のいずれかに記載の皮膚洗浄剤組成物である。
 <5> (D)成分の含有量が、0.5質量%~4質量%である前記<4>に記載の皮膚洗浄剤組成物である。
The present invention is based on the findings of the present inventors, and means for solving the above problems are as follows. Namely
<1> (A) an anionic surfactant;
(B) at least one plant extract selected from extracts of Sasa squamosa and water extracts of mint;
(C) at least one polyhydric alcohol selected from glycerin, 1,3-butylene glycol, and propylene glycol;
and wherein the mass ratio [(C)/(B)] of the content of component (C) to the content of component (B) is 3 to 30 be.
<2> The skin cleanser composition according to <1> above, wherein the extract of component (B) is Sasa serrata water and the aqueous mint extract of component (B) is peppermint oil.
<3> The content of component (A) is 5% by mass to 12% by mass,
The content of the extract of component (B) is 0.5% by mass to 1.2% by mass, and the content of the water extract of component (B) is 0.2% by mass to 0.2% by mass. 5% by mass,
The skin cleanser composition according to any one of <1> to <2> above, wherein the component (C) is 5% by mass to 10% by mass.
<4> (D) The skin cleanser composition according to any one of <1> to <3>, further comprising an amphoteric surfactant.
<5> The skin cleanser composition according to <4> above, wherein the content of component (D) is 0.5% by mass to 4% by mass.

 本発明によると、従来における前記諸問題を解決し、前記目的を達成することができ、皮膚上のバリア機能を高める常在菌は保持しながら、病原性を持つ大腸菌等に対しては高い殺菌力を有し、着色がなく液外観が良好であり、嫌味臭がなく、泡質、洗浄後の感触、手肌への刺激のなさ、及び安定性に優れる皮膚洗浄剤組成を提供することができる。 According to the present invention, it is possible to solve the above-mentioned problems in the past and achieve the above-mentioned objects. To provide a skin cleansing agent composition which is effective, has no coloration, good liquid appearance, no unpleasant odor, excellent foam quality, feel after cleansing, no irritation to hands and skin, and excellent stability. can.

(皮膚洗浄剤組成物)
 本発明の皮膚洗浄剤組成物は、(A)アニオン性界面活性剤と、(B)チシマザサ抽出物及びハッカの水抽出物から選択される少なくとも1種の植物抽出物と、(C)グリセリン、1,3-ブチレングリコール、及びプロピレングリコールから選択される少なくとも1種の多価アルコールと、を含有し、(D)両性界面活性剤を更に含有することが好ましく、更に必要に応じて、その他の成分を含有する。
(Skin cleanser composition)
The skin cleansing composition of the present invention comprises (A) an anionic surfactant, (B) at least one plant extract selected from extracts of S. japonica and water extracts of mint, (C) glycerin, 1,3-butylene glycol, and at least one polyhydric alcohol selected from propylene glycol, preferably further containing (D) an amphoteric surfactant, and if necessary, other Contains ingredients.

<(A)アニオン性界面活性剤>
 前記(A)成分としてのアニオン性界面活性剤は、主に、泡質、洗浄後の感触、及び大腸菌に対する殺菌力を向上させるために含有される。
<(A) anionic surfactant>
The anionic surfactant as the component (A) is mainly contained in order to improve foam quality, feeling after washing, and bactericidal activity against E. coli.

 前記(A)成分のアニオン性界面活性剤としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、高級脂肪酸塩、ポリオキシエチレン(POE)アルキルエーテル硫酸塩、エーテルカルボン酸塩、アミノ酸系界面活性剤などが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。これらの中でも、泡質、洗浄後の感触、及び大腸菌に対する殺菌力の点から、高級脂肪酸塩が好ましい。 The anionic surfactant of component (A) is not particularly limited and can be appropriately selected depending on the intended purpose. Salts, amino acid-based surfactants and the like are included. These may be used individually by 1 type, and may use 2 or more types together. Among these, higher fatty acid salts are preferred from the viewpoints of foam quality, feel after washing, and bactericidal activity against Escherichia coli.

-高級脂肪酸塩-
 前記(A)成分の中の前記高級脂肪酸塩としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ラウリン酸塩、ミリスチン酸塩、パルミチン酸塩、ステアリン酸塩などが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。これらの中でも、ラウリン酸塩及びミリスチン酸塩をいずれも含む高級脂肪酸塩が好ましい。
-Higher Fatty Acid Salt-
The higher fatty acid salt in the component (A) is not particularly limited and can be appropriately selected depending on the purpose. Examples include laurate, myristate, palmitate, stearate, etc. mentioned. These may be used individually by 1 type, and may use 2 or more types together. Among these, higher fatty acid salts containing both laurate and myristate are preferred.

 前記高級脂肪酸塩の対イオンとしては、特に制限はなく、目的に応じて適宜選択することができ、例えば、アルカリ金属塩、アミン塩、アミノ酸塩などが挙げられる。
 前記アルカリ金属塩としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ナトリウム塩、カリウム塩などが挙げられる。
 前記アミン塩としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、アンモニウム塩;モノエタノールアミン塩、ジエタノールアミン塩、トリエタノールアミン塩、2-アミノ-2-メチルプロパノール、2-アミノ-2-メチルプロパンジオール等のアルカノールアミン塩などが挙げられる。
 前記アミノ酸塩としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、リジン塩、アルギニン塩などが挙げられる。
 これらの中でも、泡の弾力性に優れる点で、アルカリ金属塩が好ましく、カリウム塩が特に好ましい。
The counter ion of the higher fatty acid salt is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include alkali metal salts, amine salts and amino acid salts.
The alkali metal salt is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include sodium salt and potassium salt.
The amine salt is not particularly limited and can be appropriately selected depending on the purpose. Examples include ammonium salt; monoethanolamine salt, diethanolamine salt, triethanolamine salt, and alkanolamine salts such as -amino-2-methylpropanediol.
The amino acid salt is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include lysine salts and arginine salts.
Among these, alkali metal salts are preferred, and potassium salts are particularly preferred, from the viewpoint of excellent foam elasticity.

 前記高級脂肪酸塩は、適宜合成したものを使用してもよいし、市販品を使用してもよい。
 前記高級脂肪酸塩の市販品としては、例えば、商品名で、NIKKOL ラウリン酸カリLK-120(ラウリン酸カリウム)、NIKKOL ミリスチン酸カリMK-140(ミリスチン酸カリウム)、タイソープ MNK-40(ヤシ油脂肪酸カリウム・ミリスチン酸カリウム配合液体(以上、日光ケミカルズ株式会社製)などが挙げられる。
As the higher fatty acid salt, an appropriately synthesized one may be used, or a commercially available product may be used.
Commercially available higher fatty acid salts include, for example, trade names of NIKKOL potassium laurate LK-120 (potassium laurate), NIKKOL potassium myristate MK-140 (potassium myristate), Thai Soap MNK-40 (coconut oil fatty acid), Potassium/potassium myristate mixed liquid (manufactured by Nikko Chemicals Co., Ltd.) and the like.

 前記高級脂肪酸塩は、高級脂肪酸塩として配合することも可能であるが、高級脂肪酸と、水酸化カリウム等の前記対イオンとなる塩とを別々に、配合槽中に添加して中和反応させて高級脂肪酸塩としてもよい。 The higher fatty acid salt can be blended as a higher fatty acid salt, but the higher fatty acid and the counterion salt such as potassium hydroxide are separately added to a blending tank and neutralized. may be used as a higher fatty acid salt.

 前記高級脂肪酸塩の調製に使用する前記高級脂肪酸は、適宜合成したものを使用してもよいし、市販品を使用してもよい。
 前記高級脂肪酸の市販品としては、例えば、商品名で、NAA(登録商標)-122(ラウリン酸)、NAA(登録商標)-142(ミリスチン酸)、NAA(登録商標)-160(パルミチン酸)、NAA(登録商標)-180(ステアリン酸)(以上、日油株式会社製)、Kortacid 1299(ラウリン酸)、Kortacid 1499(ミリスチン酸)(以上、Pacific Oleochemicals製)などが挙げられる。
The higher fatty acid used for preparing the higher fatty acid salt may be appropriately synthesized or a commercially available product.
Commercially available higher fatty acids include, for example, NAA (registered trademark)-122 (lauric acid), NAA (registered trademark)-142 (myristic acid), and NAA (registered trademark)-160 (palmitic acid). , NAA (registered trademark)-180 (stearic acid) (manufactured by NOF Corporation), Kortacid 1299 (lauric acid), Kortacid 1499 (myristic acid) (manufactured by Pacific Oleochemicals) and the like.

 前記ラウリン酸塩の含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、皮膚洗浄剤組成物全量に対して、2質量%~12質量%が好ましく、4質量%~10質量%がより好ましい。 The content of the laurate is not particularly limited and can be appropriately selected depending on the intended purpose. ~10% by mass is more preferred.

 前記ミリスチン酸塩の含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、皮膚洗浄剤組成物全量に対して、0.5質量%~10質量%が好ましく、1質量%~8質量%がより好ましい。 The content of the myristate salt is not particularly limited and can be appropriately selected depending on the intended purpose. % to 8% by mass is more preferred.

 前記パルミチン酸塩の含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、皮膚洗浄剤組成物全量に対して、1質量%~11質量%が好ましく、3質量%~9質量%がより好ましい。 The content of the palmitate is not particularly limited and can be appropriately selected depending on the intended purpose. ~9% by mass is more preferred.

 前記ステアリン酸塩の含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、皮膚洗浄剤組成物全量に対して、0.1質量%~3質量%が好ましく、0.2質量%~1質量%がより好ましい。 The content of the stearate is not particularly limited and can be appropriately selected depending on the purpose. .2% by mass to 1% by mass is more preferred.

-ポリオキシエチレンアルキルエーテル硫酸塩-
 前記(A)成分の中の前記ポリオキシエチレンアルキルエーテル硫酸塩としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、下記一般式(A1)で表される化合物などが挙げられる。前記ポリオキシエチレンアルキルエーテル硫酸塩は、1種単独で使用してもよいし、2種以上を併用してもよい。

Figure JPOXMLDOC01-appb-C000001
- Polyoxyethylene Alkyl Ether Sulfate -
The polyoxyethylene alkyl ether sulfate in the component (A) is not particularly limited and can be appropriately selected depending on the intended purpose. For example, compounds represented by the following general formula (A1) mentioned. The said polyoxyethylene alkyl ether sulfate may be used individually by 1 type, and may use 2 or more types together.
Figure JPOXMLDOC01-appb-C000001

 前記一般式(A1)中、Rはアルキル基を示し、前記アルキル基部分の炭素数としては、10~14が好ましい。 In general formula (A1), R 1 represents an alkyl group, and the alkyl group portion preferably has 10 to 14 carbon atoms.

 前記一般式(A1)中、nはエチレンオキサイド(E.O.)の平均付加モル数を示し、前記エチレンオキサイドの平均付加モル数としては、1~5が好ましい。 In the general formula (A1), n represents the average added mole number of ethylene oxide (E.O.), and the average added mole number of ethylene oxide is preferably 1 to 5.

 前記一般式(A1)中、Xは、アルカリ金属、又はアンモニウムを示す。
 前記アルカリ金属としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ナトリウム、カリウムなどが挙げられる。
In the general formula (A1), X represents an alkali metal or ammonium.
The alkali metal is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include sodium and potassium.

 前記ポリオキシエチレンアルキルエーテル硫酸塩の具体例としては、ポリオキシエチレン(1)ラウリルエーテル硫酸ナトリウム、ポリオキシエチレン(2)ラウリルエーテル硫酸ナトリウム(別名:POE(2)ラウレス硫酸ナトリウム)、ポリオキシエチレン(3)ラウリルエーテル硫酸ナトリウム(別名:POE(3)ラウレス硫酸ナトリウム)、ポリオキシエチレン(4)ラウリルエーテル硫酸ナトリウム、ポリオキシエチレン(5)ラウリルエーテル硫酸ナトリウム、ポリオキシエチレン(3)アルキル(C12,13)エーテル硫酸ナトリウム、ポリオキシエチレン(2)ラウリルエーテル硫酸アンモニウム、ポリオキシエチレン(3)ラウリルエーテル硫酸アンモニウムなどが挙げられる。
 なお、前記( )内の数値は、エチレンオキサイド(E.O.)の平均付加モル数(n)を表す。
Specific examples of the polyoxyethylene alkyl ether sulfate include polyoxyethylene (1) sodium lauryl ether sulfate, polyoxyethylene (2) sodium lauryl ether sulfate (also known as POE (2) sodium laureth sulfate), polyoxyethylene (3) sodium lauryl ether sulfate (also known as POE (3) sodium laureth sulfate), polyoxyethylene (4) sodium lauryl ether sulfate, polyoxyethylene (5) sodium lauryl ether sulfate, polyoxyethylene (3) alkyl (C12 , 13) sodium ether sulfate, polyoxyethylene (2) ammonium lauryl ether sulfate, polyoxyethylene (3) ammonium lauryl ether sulfate, and the like.
In addition, the numerical value in said () represents the average addition mole number (n) of ethylene oxide (E.O.).

 前記ポリオキシエチレンアルキルエーテル硫酸塩は、適宜合成したものを使用してもよいし、市販品を使用してもよい。
 前記ポリオキシエチレンアルキルエーテル硫酸塩の市販品としては、例えば、エマール20C(ポリオキシエチレン(3)ラウリルエーテル硫酸ナトリウム)、エマール270J(ポリオキシエチレン(2)ラウリルエーテル硫酸ナトリウム)、エマール20CM(ポリオキシエチレン(3)アルキル(C12,13)エーテル硫酸ナトリウム)、エマール125HP(ポリオキシエチレン(1)ラウリルエーテル硫酸ナトリウム)(以上、花王株式会社製)、アルスコープ(登録商標)DA-330S(ポリオキシエチレン(3)アルキル(C12,13)エーテル硫酸ナトリウム)、アルスコープ(登録商標)A-225B(ポリオキシエチレン(2)ラウリルエーテル硫酸アンモニウム)(以上、東邦化学工業株式会社製)、シノリンSPE-1150(ポリオキシエチレン(1)ラウリルエーテル硫酸ナトリウム)、シノリンSPE-1250(ポリオキシエチレン(2)ラウリルエーテル硫酸ナトリウム)、シノリンSPE-1350(ポリオキシエチレン(3)ラウリルエーテル硫酸ナトリウム)(以上、新日本理化株式会社製)、Texapon(テキサポン)(登録商標) N70(ポリオキシエチレン(2)ラウリルエーテル硫酸ナトリウム)(BASF社製)などが挙げられる。
As the polyoxyethylene alkyl ether sulfate, an appropriately synthesized one may be used, or a commercially available product may be used.
Commercially available polyoxyethylene alkyl ether sulfates include, for example, Emal 20C (polyoxyethylene (3) sodium lauryl ether sulfate), Emal 270J (polyoxyethylene (2) sodium lauryl ether sulfate), Emal 20CM (poly Oxyethylene (3) alkyl (C12,13) sodium ether sulfate), Emal 125HP (polyoxyethylene (1) sodium lauryl ether sulfate) (manufactured by Kao Corporation), Alscope (registered trademark) DA-330S (poly Oxyethylene (3) alkyl (C12,13) sodium ether sulfate), Alscope (registered trademark) A-225B (polyoxyethylene (2) ammonium lauryl ether sulfate) (manufactured by Toho Chemical Industry Co., Ltd.), Shinoline SPE- 1150 (polyoxyethylene (1) sodium lauryl ether sulfate), Shinoline SPE-1250 (polyoxyethylene (2) sodium lauryl ether sulfate), Shinoline SPE-1350 (polyoxyethylene (3) sodium lauryl ether sulfate) (above, New Japan Chemical Co., Ltd.), Texapon (registered trademark) N70 (polyoxyethylene (2) sodium lauryl ether sulfate) (manufactured by BASF), and the like.

-エーテルカルボン酸塩-
 前記(A)成分の中の前記エーテルカルボン酸塩としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、下記一般式(A2)又は(A3)で表される化合物などが挙げられる。前記エーテルカルボン酸塩は、1種単独で使用してもよいし、2種以上を併用してもよい。

Figure JPOXMLDOC01-appb-C000002
- Ether carboxylate -
The ether carboxylate in the component (A) is not particularly limited and can be appropriately selected depending on the intended purpose. is mentioned. The ether carboxylates may be used singly or in combination of two or more.
Figure JPOXMLDOC01-appb-C000002

 前記一般式(A2)及び(A3)中、Rは炭素数5~23の直鎖若しくは分岐鎖のアルキル基若しくはアルケニル基、又は炭素数5~23の直鎖若しくは分岐鎖のアルキル基若しくはアルケニル基で置換されたフェニル基を示し、前記R部分の炭素数としては、10~14が好ましい。 In the general formulas (A2) and (A3), R 2 is a linear or branched alkyl group or alkenyl group having 5 to 23 carbon atoms, or a linear or branched alkyl group or alkenyl group having 5 to 23 carbon atoms represents a phenyl group substituted with a group, and the number of carbon atoms in the R 2 moiety is preferably 10 to 14.

 前記一般式(A2)中、Rは炭素数2~4のアルキレン基を示し、前記R部分の炭素数としては、2が好ましい。前記Rは、それぞれ同一であってもよく、異なっていてもよい。 In general formula (A2), R 3 represents an alkylene group having 2 to 4 carbon atoms, and the number of carbon atoms in the R 3 moiety is preferably 2. Each R 3 may be the same or different.

 前記一般式(A2)中、oは1~20のアルキレンオキサイドの平均付加モル数を示し、前記アルキレンオキサイドの平均付加モル数としては、1~5が好ましい。 In the general formula (A2), o represents an average added mole number of 1 to 20 alkylene oxide, and the average added mole number of the alkylene oxide is preferably 1 to 5.

 前記一般式(A2)及び(A3)中、Mは、水素原子、アルカリ金属、アルカリ土類金属、アンモニウム、又は塩基性アミノ酸を示す。 In general formulas (A2) and (A3), M1 represents a hydrogen atom, an alkali metal, an alkaline earth metal, ammonium, or a basic amino acid.

 前記一般式(A2)又は(A3)で表されるエーテルカルボン酸塩の具体例としては、ポリオキシエチレン(3)ラウリルエーテル酢酸ナトリウム、ポリオキシエチレン(4)ラウリルエーテル酢酸カリウム、ラウリルグリコール酢酸ナトリウムなどが挙げられる。
 なお、前記( )内の数値は、アルキレンオキサイドの平均付加モル数(o)を表す。
Specific examples of the ether carboxylate represented by the general formula (A2) or (A3) include polyoxyethylene (3) sodium lauryl ether acetate, polyoxyethylene (4) potassium lauryl ether acetate, and sodium lauryl glycol acetate. etc.
In addition, the numerical value in said () represents the average added mole number (o) of alkylene oxide.

 前記エーテルカルボン酸塩は、適宜合成したものを使用してもよいし、市販品を使用してもよい。
 前記エーテルカルボン酸塩の市販品としては、例えば、エナジコールEC-30(ポリオキシエチレン(3)ラウリルエーテル酢酸ナトリウム、ライオン・スペシャリティ・ケミカルズ株式会社製)、ビューライト LCA-25F(ポリオキシエチレン(3)ラウリルエーテル酢酸ナトリウム)、ビューライト LCA-30D(ポリオキシエチレン(3)ラウリルエーテル酢酸ナトリウム)、ビューライト LCA-H(ポリオキシエチレン(4)ラウリルエーテル酢酸)、ビューライト LCA-25NH(ラウレス-4カルボン酸)、ビューライト SHAA(ラウリルグリコールカルボン酸ナトリウム)、ビューライト LCA(ポリオキシエチレン(3)ラウリルエーテル酢酸ナトリウム)(以上、三洋化成工業株式会社製)、カオーアキポRLM-45NV(ポリオキシエチレン(4.5)ラウリルエーテル酢酸ナトリウム)、カオーアキポRLM-100NV(ポリオキシエチレン(10)ラウリルエーテル酢酸ナトリウム)(以上、花王株式会社製)などが挙げられる。
 なお、前記( )内の数値は、アルキレンオキサイドの平均付加モル数(o)を表す。
The ether carboxylate may be appropriately synthesized or may be a commercially available product.
Examples of commercially available ether carboxylates include Enagicol EC-30 (polyoxyethylene (3) sodium lauryl ether acetate, manufactured by Lion Specialty Chemicals Co., Ltd.), Beaulite LCA-25F (polyoxyethylene (3 ) Sodium lauryl ether acetate), Beaulite LCA-30D (polyoxyethylene (3) sodium lauryl ether acetate), Beaulite LCA-H (polyoxyethylene (4) lauryl ether acetic acid), Beaulite LCA-25NH (Laureth- 4 carboxylic acid), Beaulite SHAA (sodium lauryl glycol carboxylate), Beaulite LCA (polyoxyethylene (3) sodium lauryl ether acetate) (manufactured by Sanyo Chemical Industries, Ltd.), Kao Akipo RLM-45NV (polyoxyethylene (4.5) sodium lauryl ether acetate), Kaoakipo RLM-100NV (polyoxyethylene (10) sodium lauryl ether acetate) (manufactured by Kao Corporation), and the like.
In addition, the numerical value in said () represents the average added mole number (o) of alkylene oxide.

-アミノ酸系界面活性剤-
 前記(A)成分の中の前記アミノ酸系界面活性剤としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、下記一般式(A4)で表される化合物などが挙げられる。前記アミノ酸系界面活性剤は、1種単独で使用してもよいし、2種以上を併用してもよい。

Figure JPOXMLDOC01-appb-C000003
-Amino acid-based surfactant-
The amino acid-based surfactant in the component (A) is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include compounds represented by the following general formula (A4). . The amino acid-based surfactants may be used singly or in combination of two or more.
Figure JPOXMLDOC01-appb-C000003

 前記一般式(A4)中、Rは炭素数5~23の直鎖若しくは分岐鎖のアルキル基若しくはアルケニル基、又は炭素数5~23の直鎖若しくは分岐鎖のアルキル基若しくはアルケニル基で置換されたフェニル基を示し、前記R部分の炭素数としては、8~18が好ましい。 In the general formula (A4), R 4 is substituted with a linear or branched alkyl or alkenyl group having 5 to 23 carbon atoms, or a linear or branched alkyl or alkenyl group having 5 to 23 carbon atoms. The number of carbon atoms in the R 4 moiety is preferably 8 to 18.

 前記一般式(A4)中、Rは、水素原子又は炭素数1~3のアルキル基を示す。 In general formula (A4), R 5 represents a hydrogen atom or an alkyl group having 1 to 3 carbon atoms.

 前記一般式(A4)中、R及びRは、水素原子又は-(CH-COOMを示す。前記R及び前記Rは、同一であってもよく、異なっていてもよい。 In general formula (A4), R 6 and R 7 represent a hydrogen atom or -(CH 2 ) m -COOM 2 . Said R6 and said R7 may be the same or different.

 前記一般式(A4)中、m及びnは0~20の数を示す。前記m及び前記nは、同一であってもよく、異なっていてもよい。 In the general formula (A4), m and n represent numbers from 0 to 20. Said m and said n may be the same or different.

 前記一般式(A4)中、M及びMは、水素原子、アルカリ金属、アルカリ土類金属、アンモニウム、又は塩基性アミノ酸を示す。前記M及び前記Mは、同一であってもよく、異なっていてもよい。 In general formula (A4), M 1 and M 2 represent a hydrogen atom, an alkali metal, an alkaline earth metal, ammonium, or a basic amino acid. The M 1 and the M 2 may be the same or different.

 前記アミノ酸系界面活性剤の親水部のアミノ酸構造としては、特に制限はなく、目的に応じて適宜選択することができるが、グリシン、グルタミン酸、メチルアラニンが好ましい。 The amino acid structure of the hydrophilic portion of the amino acid-based surfactant is not particularly limited and can be appropriately selected depending on the purpose, but glycine, glutamic acid, and methylalanine are preferred.

 前記一般式(A4)で表されるアミノ酸系界面活性剤の具体例としては、N-ココイル-グリシンカリウム(N-ヤシ油脂肪酸アシルグリシンカリウム)、N-ココイル-グリシンナトリウム(N-ヤシ油脂肪酸アシルグリシンナトリウム)等のN-アシル-グリシン及びその塩;N-ミリストイル-N-カルボキシエチル-グリシンナトリウム等のN-アシル-N-カルボキシエチル-グリシン及びその塩;N-ミリストイル-L-グルタミン酸ナトリウム、N-ラウロイル-L-グルタミン酸ナトリウム、N-ミリストイル-L-グルタミン酸カリウム、N-ヤシ油脂肪酸アシル-L-グルタミン酸カリウム、N-ヤシ油脂肪酸アシル-L-グルタミン酸ナトリウム、N-パーム脂肪酸アシル-L-グルタミン酸ナトリウム、N-ステアロイル-L-グルタミン酸ナトリウム等のN-アシルグルタミン酸及びその塩;N-ラウロイル-N-メチル-β-アラニンカリウム、ラウロイルメチル-β-アラニンナトリウム、N-ラウロイル-N-メチル-β-アラニントリエタノールアミン、ヤシ油脂肪酸メチルアラニンナトリウム、N-ヤシ油脂肪酸アシル-DL-アラニントリエタノールアミン等のN-アシル-N-メチル-β-アラニン及びその塩;N-ココイル-β-アラニントリエタノールアミン等のN-アシル-β-アラニン及びその塩;ヤシ油脂肪酸サルコシントリエタノールアミン、ミリストイルメチルアミノ酢酸ナトリウム等のアシルサルコシン及びその塩などが挙げられる。 Specific examples of the amino acid-based surfactant represented by the general formula (A4) include N-cocoyl-glycine potassium (N-coconut fatty acid acylglycine potassium), N-cocoyl-glycine sodium (N-coconut fatty acid N-acyl-glycine such as sodium acylglycinate) and salts thereof; N-acyl-N-carboxyethyl-glycine such as sodium N-myristoyl-N-carboxyethyl-glycine and salts thereof; sodium N-myristoyl-L-glutamate , N-lauroyl-L-sodium glutamate, potassium N-myristoyl-L-glutamate, potassium N-cocoate acyl-L-glutamate, N-cocoate acyl-L-sodium glutamate, N-palm acyl-L - N-acylglutamic acid and its salts such as sodium glutamate, sodium N-stearoyl-L-glutamate; N-lauroyl-N-methyl-β-alanine potassium, lauroylmethyl-β-alanine sodium, N-lauroyl-N-methyl - N-acyl-N-methyl-β-alanine such as β-alaninetriethanolamine, sodium cocoate methylalanine, N-cocoate acyl-DL-alaninetriethanolamine and salts thereof; N-cocoyl-β -N-acyl-β-alanine such as alanine triethanolamine and salts thereof; acyl sarcosine such as coconut oil fatty acid sarcosine triethanolamine and sodium myristoylmethylaminoacetate and salts thereof;

 前記アミノ酸系界面活性剤は、適宜合成したものを使用してもよいし、市販品を使用してもよい。
 前記アミノ酸系界面活性剤の市販品としては、例えば、商品名で、アミライト(登録商標)GCK-11(N-ヤシ油脂肪酸アシルグリシンカリウム)、アミライト(登録商標)GCK-12K(N-ヤシ油脂肪酸アシルグリシンカリウム)、アミライト(登録商標)GCS-12K(N-ヤシ油脂肪酸アシルグリシンナトリウム)、アミライト(登録商標)GCS-11(N-ヤシ油脂肪酸アシルグリシンナトリウム)、アミソフト(登録商標)CS-11(N-ミリストイル-L-グルタミン酸ナトリウム)、アミソフト(登録商標)CS-22(N-ヤシ油脂肪酸アシル-L-グルタミン酸ナトリウム)、アミソフト(登録商標)LS-11(N-ラウロイル-L-グルタミン酸ナトリウム)、アミソフト(登録商標)MS-11(N-ミリストイル-L-グルタミン酸ナトリウム)、アミソフト(登録商標)HS-11P(N-ステアロイル-L-グルタミン酸ナトリウム)、アミソフト(登録商標)HS-11P(F)(N-ステアロイル-L-グルタミン酸ナトリウム)、アミソフト(登録商標)HS21(N-ステアロイル-L-グルタミン酸ジナトリウム)、アミライト(登録商標)ACS-12(ココイルアラニンナトリウム)(以上、味の素ヘルシーサプライ株式会社製)、アミノサーファクト(登録商標)AMMS-P1(N-ミリストイル-L-グルタミン酸ナトリウム、旭化成ケミカルズ株式会社製)、NIKKOL サルコシネート MN(ミリストイルメチルアミノ酢酸ナトリウム)、NIKKOL アラニネート LN-30(ラウロイルメチル-β-アラニンナトリウム)(以上、日光ケミカルズ株式会社製)、アラノンACE(ヤシ油脂肪酸メチルアラニンナトリウム)、アラノンAME(ミリストイルメチル-β-アラニンナトリウム)、アラノンALE(ラウロイルメチル-β-アラニンナトリウム)(以上、川研ファインケミカル株式会社製)、エナジコール L-30AN(ラウロイルメチル-β-アラニンナトリウム、ライオン・スペシャリティ・ケミカルズ株式会社製)、ソフティルトAT-L(ラウロイルメチル-β-アラニンナトリウム、日油株式会社製)などが挙げられる。
As the amino acid-based surfactant, an appropriately synthesized one may be used, or a commercially available product may be used.
Commercially available amino acid-based surfactants include, for example, trade names of Amylite (registered trademark) GCK-11 (potassium N-coconut oil fatty acid acylglycine) and Amylite (registered trademark) GCK-12K (N-coconut oil Potassium fatty acid acylglycinate), Amylite (registered trademark) GCS-12K (sodium N-coconut acylglycinate), Amylite (registered trademark) GCS-11 (sodium N-coconut acylglycinate), Amisoft (registered trademark) CS -11 (N-myristoyl-L-sodium glutamate), Amisoft (registered trademark) CS-22 (N-coconut fatty acid acyl-L-glutamate sodium), Amisoft (registered trademark) LS-11 (N-lauroyl-L- sodium glutamate), Amisoft® MS-11 (N-myristoyl-L-sodium glutamate), Amisoft® HS-11P (N-stearoyl-L-sodium glutamate), Amisoft® HS-11P (F) (N-stearoyl-L-glutamate sodium), Amisoft (registered trademark) HS21 (N-stearoyl-L-glutamate disodium), Amilite (registered trademark) ACS-12 (cocoyl alanine sodium) (above, Ajinomoto Healthy Supply Co., Ltd.), Amino Surfact (registered trademark) AMMS-P1 (N-myristoyl-L-glutamate sodium, Asahi Kasei Chemicals Corp.), NIKKOL Sarcosinate MN (myristoylmethylaminoacetate sodium), NIKKOL Alaninate LN-30 ( Sodium lauroylmethyl-β-alanine) (manufactured by Nikko Chemicals Co., Ltd.), Alanone ACE (coconut fatty acid methylalanine sodium), Alanone AME (myristoylmethyl-β-alanine sodium), Alanone ALE (lauroylmethyl-β-alanine) sodium) (manufactured by Kawaken Fine Chemicals Co., Ltd.), Enagicol L-30AN (Lauroylmethyl-β-alanine sodium, Lion Specialty Chemicals Co., Ltd.), Softilt AT-L (Lauroylmethyl-β-alanine sodium, Japan manufactured by Yu Co., Ltd.).

 前記(A)成分のアニオン性界面活性剤の含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、泡質、洗浄後の感触、及び大腸菌に対する殺菌力の点から、前記皮膚洗浄剤組成物全量に対して、3質量%~14質量%が好ましく、5質量%~12質量%がより好ましい。前記(A)成分の含有量が、3質量%以上であると、泡質、洗浄後の感触、及び大腸菌に対する殺菌力が良好であり、14質量%以下であると、安定性、特に低温安定性が良好である。 The content of the anionic surfactant of component (A) is not particularly limited and can be appropriately selected according to the purpose. , preferably 3% by mass to 14% by mass, more preferably 5% by mass to 12% by mass, based on the total amount of the skin cleanser composition. When the content of component (A) is 3% by mass or more, the foam quality, feeling after washing, and bactericidal activity against E. coli are good, and when it is 14% by mass or less, stability, particularly low temperature stability, is obtained. Good properties.

<(B)チシマザサ抽出物及びハッカの水抽出物から選択される少なくとも1種の植物抽出物>
 前記(B)成分としての植物抽出物は、チシマザサ抽出物及びハッカの水抽出物油から選択される少なくとも1種であり、主に、大腸菌に対する殺菌力を向上させるために含有される。
<(B) At least one plant extract selected from extracts of bamboo shoots and water extracts of mint>
The plant extract as the component (B) is at least one selected from extracts of Sasa chinensis and water extract oil of mint, and is mainly contained in order to improve bactericidal activity against Escherichia coli.

-チシマザサ抽出物-
 前記チシマザサ抽出物の抽出原料として使用するチシマザサ(Sasa kurilensis)は、イネ科(Poaceae)タケ亜科(Bambusoideae)ササ属(Sasa)に属する単子葉植物である。日本国内で広く自生又は栽培されており、容易に入手可能である。
- Sasa extract -
Sasa kurilensis used as a raw material for the Sasa kurilensis extract is a monocotyledonous plant belonging to the genus Sasa , Bambusoidea , Poaceae . It is widely grown or cultivated in Japan and is easily available.

 前記抽出原料として使用する前記チシマザサは、チシマザサの変種であってもよい。
 前記チシマザサの変種としては、本発明の効果を奏する限り、特に制限はなく、目的に応じて適宜選択することができ、例えば、キアケボノネマガリ、ギンタイチシマ、キンタイチシマ、キンメイチシマ、シモフリネマガリ、タカラネマガリ、チャボコンシマチシマ、チャボマキバ、チャボシモフリチシマ、ノチザエキフネマガリ、マキバネマガリ、ミイロチシマ、変種エゾネマガリ、ナガバネマガリダケなどが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。
 本明細書において、チシマザサ及びその変種を併せて「チシマザサ類」と称する。また、前記チシマザサ類の抽出物を「チシマザサ抽出物」と称する。
 前記チシマザサ類の入手方法としては、特に制限はなく、目的に応じて適宜選択することができ、自然界から採取してもよいし、市販品を用いてもよい。
The bamboo grass used as the raw material for extraction may be a variety of bamboo grass.
Variants of the above-mentioned Chishimazasa are not particularly limited as long as the effect of the present invention is exhibited, and can be appropriately selected according to the purpose. Examples include konshimachishima, chabomakiba, chaboshimofurichishima, nochizaekifunemagari, makibanemagari, miirochishima, variant ezonemagari, and nagabanemagaridake. These may be used individually by 1 type, and may use 2 or more types together.
In the present specification, Sasa serrata and its variants are collectively referred to as ``Sasa family''. Moreover, the extract of the above-mentioned Sasa spp.
There is no particular limitation on the method of obtaining the above-mentioned Sasa spp., it can be appropriately selected according to the purpose, and it may be collected from the natural world or commercially available.

 前記チシマザサ抽出物は、植物の抽出に一般的に用いられる方法により容易に得ることができるが、大腸菌に対する殺菌力及び液外観の点で、水蒸気蒸留法、圧搾抽出法などの抽出法で抽出したものが好ましく、前記抽出物の精製物がより好ましい。これらの抽出法は、1種単独で行ってもよく、2種以上を組み合わせて行ってもよい。 The Sasa extract can be easily obtained by a method generally used for extracting plants, but it is extracted by an extraction method such as a steam distillation method or a compression extraction method in terms of bactericidal activity against Escherichia coli and liquid appearance. is preferred, and a purified product of the extract is more preferred. These extraction methods may be performed singly or in combination of two or more.

 前記抽出原料として使用する前記チシマザサ類の使用部位としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、花、蕾、果実、果皮、種子、種皮、茎、葉、枝、枝葉等の地上部;根、根茎等の地下部などが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、前記チシマザサ類の使用部位としては、地上部が好ましい。 The use part of the Sasa spp. used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. above-ground parts such as branches and leaves; underground parts such as roots and rhizomes. These may be used individually by 1 type, and may use 2 or more types together. Among these, the above-ground part is preferable as the part to be used of the above-mentioned Sasa.

 前記抽出原料として使用する前記チシマザサ類の大きさとしては、特に制限はなく、目的に応じて適宜選択することができ、例えば、採取したそのままの大きさ、切断した所望の大きさ、微粉(パウダー)化された大きさなどが挙げられる。 The size of the bamboo grass used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. ) and the like.

 前記抽出原料として使用する前記チシマザサ類の状態としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、採取したそのままの状態、乾燥した状態、粉砕した状態などが挙げられる。 The state of the bamboo grass used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose.

 前記抽出原料として使用する前記チシマザサ類を乾燥した状態にする方法としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、天日で乾燥する方法、通常使用される乾燥機を用いて乾燥する方法などが挙げられる。 The method for drying the bamboo grass used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. and a method of drying using

 前記抽出原料として使用する前記チシマザサ類を前記粉砕した状態にする方法としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ミキサー、シュガーミル、パワーミル、ジェットミル、衝撃式粉砕機等により粉砕する方法などが挙げられる。 The method for pulverizing the bamboo grass used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. Examples include a method of pulverizing with a pulverizer or the like.

 前記チシマザサ抽出物を水蒸気蒸留法で調製する場合、その抽出溶媒として用いられる水としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、純水、水道水、井戸水、鉱泉水、鉱水、温泉水、湧水、淡水、精製水、熱水、イオン交換水、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水などが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。 In the case of preparing the extract of S. phlox by steam distillation, the water used as the extraction solvent is not particularly limited and can be appropriately selected according to the purpose. Water, mineral water, hot spring water, spring water, fresh water, purified water, hot water, ion-exchanged water, physiological saline, phosphate buffer, phosphate buffered physiological saline and the like. These may be used individually by 1 type, and may use 2 or more types together.

 前記抽出溶媒の使用量としては、特に制限はなく、目的に応じて適宜選択することができる。 The amount of the extraction solvent used is not particularly limited, and can be appropriately selected according to the purpose.

 前記チシマザサ抽出物の抽出条件(抽出時間、抽出温度、圧力等の雰囲気条件など)としては、特に制限はなく、公知の方法の中から目的に応じて適宜選択することができる。
 前記圧搾抽出法の場合は、低温及び高圧で行われることが好ましく、一般的に、抽出温度が70℃以下、圧力が100mmHg~700mmHgの減圧下で行われる。
The extraction conditions (atmospheric conditions such as extraction time, extraction temperature, pressure, etc.) for the extract of S. magnolia are not particularly limited, and can be appropriately selected from known methods according to the purpose.
The compression extraction method is preferably carried out at a low temperature and a high pressure. Generally, the extraction temperature is 70° C. or less and the pressure is reduced from 100 mmHg to 700 mmHg.

 前記チシマザサ抽出物の状態としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、前記チシマザサ抽出物そのものであってもよく、前記チシマザサ抽出物の粗精製物又は精製物、前記チシマザサ抽出物の濃縮物、前記チシマザサ抽出物の希釈物、前記チシマザサ抽出物の乾燥物などであってもよい。また、前記チシマザサ抽出物は、前記チシマザサ抽出物の乾燥物を、再度水に混合又は溶解させたものであってもよい。 The state of the Sasa serrata extract is not particularly limited, and can be appropriately selected according to the purpose. It may be a concentrate of the extract, a diluted product of the extract, a dried product of the extract of the bamboo grass, or the like. In addition, the extract of Sasa serrata may be obtained by mixing or dissolving the dried Sasa extract again in water.

 これらの中でも、前記チシマザサ抽出物としては、チシマザサを低温高圧圧搾抽出法で抽出及び精製したチシマザサ水が好ましい。
 このようなチシマザサ抽出物の市販品としては、例えば、商品名で、アクアアロマ クマザサ(アリスタヘルスアンドニュートリションサイエンス株式会社製)、チシマザサ水 K2-C(日本ハルマ株式会社製)などが挙げられる。
Among these, as the extract of Sasa serrata, it is preferable to use Sasa serrata water obtained by extracting and purifying Sasa serrata by low-temperature and high-pressure extraction.
Commercially available products of such Sasa extract include, for example, Aqua Aroma Kumazasa (manufactured by Arista Health and Nutrition Science Co., Ltd.) and Sasa Sasa Water K2-C (manufactured by Nihon Haruma Co., Ltd.).

 前記チシマザサ抽出物の含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、大腸菌に対する殺菌力の点から、前記皮膚洗浄剤組成物全量に対して、0.5質量%~1.5質量%が好ましく、0.5質量%~1.2質量%がより好ましい。前記チシマザサ抽出物の含有量が、0.5質量%以上又は1.5質量%以下であると、大腸菌に対する殺菌力が良好である。 The content of the extract of Sasa chinensis is not particularly limited and can be appropriately selected according to the purpose. % to 1.5% by mass, more preferably 0.5% to 1.2% by mass. When the content of the Sasa extract is 0.5% by mass or more or 1.5% by mass or less, the bactericidal activity against Escherichia coli is good.

-ハッカの水抽出物-
 前記ハッカの水抽出物の抽出原料として使用するハッカは、シソ科(Lamiaceae)ハッカ属(Mentha)に属する植物であり、多くの種は多年草だが、一年草の種もある。日本国内で広く自生又は栽培されており、容易に入手可能である。
- Mint water extract -
The mint used as a raw material for the aqueous mint extract is a plant belonging to the genus Mentha in the family Lamiaceae , and most of the species are perennials, but some species are annuals. It is widely grown or cultivated in Japan and is easily available.

 前記ハッカ属(Mentha)に属する植物としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ニホンハッカ(別名:ワシュハッカ)、ミズハッカ、ベルガモットハッカ、ミドリハッカ、セイヨウハッカ、ヨウシュハッカなどが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、ニホンハッカ、ヨウシュハッカが好ましい。
 前記ハッカ属に属する植物の入手方法としては、特に制限はなく、目的に応じて適宜選択することができ、自然界から採取してもよいし、市販品を用いてもよい。
The plant belonging to the genus Mentha is not particularly limited and can be appropriately selected depending on the intended purpose. mentioned. These may be used individually by 1 type, and may use 2 or more types together. Among these, Japanese mint and yellow mint are preferable.
The method for obtaining the plant belonging to the Mentha genus is not particularly limited, and can be appropriately selected depending on the intended purpose.

 前記ハッカの水抽出物は、植物の抽出に一般的に用いられる方法により容易に得ることができるが、大腸菌に対する殺菌力及び液外観の点で、水蒸気蒸留法で抽出及び精製した抽出物が好ましい。 The water extract of mint can be easily obtained by a method commonly used for extracting plants, but an extract extracted and purified by a steam distillation method is preferable in terms of bactericidal activity against Escherichia coli and liquid appearance. .

 前記抽出原料として使用する前記ハッカ属に属する植物の使用部位としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、花、蕾、果実、果皮、種子、種皮、茎、葉、枝、枝葉等の地上部;根、根茎等の地下部などが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。これらの中でも、前記ハッカ属に属する植物の使用部位としては、地上部が好ましい。 The used part of the plant belonging to the genus Mentha used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. Aerial parts such as leaves, branches, branches and leaves; and underground parts such as roots and rhizomes. These may be used individually by 1 type, and may use 2 or more types together. Among these, the above-ground part is preferable as the used part of the plant belonging to the genus Mentha.

 前記抽出原料として使用する前記ハッカ属に属する植物の大きさとしては、特に制限はなく、目的に応じて適宜選択することができ、例えば、採取したそのままの大きさ、切断した所望の大きさ、微粉(パウダー)化された大きさなどが挙げられる。 The size of the plant belonging to the genus Mentha used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. Examples thereof include a size in which fine powder is formed.

 前記抽出原料として使用する前記ハッカ属に属する植物の状態としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、採取したそのままの状態、乾燥した状態、粉砕した状態、搾汁の状態などが挙げられる。 The state of the plant belonging to the genus Mentha used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. The state of the juice etc. are mentioned.

 前記抽出原料として使用する前記ハッカ属に属する植物を乾燥した状態にする方法としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、天日で乾燥する方法、通常使用される乾燥機を用いて乾燥する方法などが挙げられる。 The method for drying the plant belonging to the genus Mentha used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. and a method of drying using a drier.

 前記抽出原料として使用する前記ハッカ属に属する植物を前記粉砕した状態にする方法としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ミキサー、シュガーミル、パワーミル、ジェットミル、衝撃式粉砕機等により粉砕する方法などが挙げられる。 The method for pulverizing the plant belonging to the genus Mentha used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. , a method of pulverizing with an impact pulverizer or the like.

 前記抽出原料として使用する前記ハッカ属に属する植物を前記搾汁の状態にする方法としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、圧搾などが挙げられる。 The method for squeezing the plant belonging to the genus Mentha used as the raw material for extraction is not particularly limited and can be appropriately selected according to the purpose. Examples include pressing.

 前記ハッカの水抽出物の抽出溶媒として用いられる水としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、純水、水道水、井戸水、鉱泉水、鉱水、温泉水、湧水、淡水、精製水、熱水、イオン交換水、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水などが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。 The water used as an extraction solvent for the mint water extract is not particularly limited and can be appropriately selected according to the purpose. Spring water, fresh water, purified water, hot water, ion-exchanged water, physiological saline, phosphate buffer, phosphate buffered physiological saline, and the like. These may be used individually by 1 type, and may use 2 or more types together.

 前記抽出溶媒の使用量としては、特に制限はなく、目的に応じて適宜選択することができる。 The amount of the extraction solvent used is not particularly limited, and can be appropriately selected according to the purpose.

 前記ハッカの水抽出物の抽出条件(抽出時間、抽出温度、圧力等の雰囲気条件など)としては、特に制限はなく、公知の方法の中から目的に応じて適宜選択することができる。 The extraction conditions (atmospheric conditions such as extraction time, extraction temperature, pressure, etc.) for the water extract of mint are not particularly limited, and can be appropriately selected from known methods according to the purpose.

 前記ハッカの水抽出物の状態としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、前記ハッカの水抽出物そのものであってもよく、前記ハッカの水抽出物の粗精製物又は精製物、前記ハッカの水抽出物の濃縮物、前記ハッカの水抽出物の希釈物、前記ハッカの水抽出物の乾燥物などであってもよい。また、前記ハッカの水抽出物は、前記ハッカの水抽出物の乾燥物を、再度水に混合又は溶解させたものであってもよい。 The state of the mint water extract is not particularly limited and can be appropriately selected according to the purpose. It may be a purified product or a purified product, a concentrate of the mint aqueous extract, a diluted mint aqueous extract, a dried mint aqueous extract, or the like. The mint water extract may be obtained by remixing or dissolving the dried mint water extract in water.

 これらの中でも、前記ハッカの水抽出物としては、ハッカ属に属する植物を水蒸気蒸留法で抽出及び精製したハッカ油が好ましい。
 このようなハッカの水抽出物の市販品としては、例えば、商品名で、ハッカ油(鈴木薄荷株式会社製)、薄荷白油(長岡実業株式会社製)などが挙げられる。
Among these, the water extract of mint is preferably mint oil obtained by extracting and refining a plant belonging to the genus Mentha by steam distillation.
Commercially available products of such a water extract of mint include, for example, mint oil (manufactured by Suzuki Mint Co., Ltd.) and peppermint white oil (manufactured by Nagaoka Jitsugyo Co., Ltd.).

 前記ハッカの水抽出物の含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、大腸菌に対する殺菌力及び臭いの点から、前記皮膚洗浄剤組成物全量に対して、0.1質量%~0.6質量%が好ましく、0.2質量%~0.5質量%がより好ましい。前記ハッカの水抽出物の含有量が、0.1質量%以上であると、大腸菌に対する殺菌力が良好であり、0.6質量%以下であると、特異的な臭いを抑制することができる。 The content of the mint water extract is not particularly limited and can be appropriately selected according to the intended purpose. 0.1% by mass to 0.6% by mass is preferable, and 0.2% by mass to 0.5% by mass is more preferable. When the content of the mint aqueous extract is 0.1% by mass or more, the bactericidal activity against Escherichia coli is good, and when it is 0.6% by mass or less, a specific odor can be suppressed. .

<(C)グリセリン、1,3-ブチレングリコール、及びプロピレングリコールから選択される少なくとも1種の多価アルコール>
 前記(C)成分としての多価アルコールは、主に、泡質及び洗浄後の感触を向上させるために含有される。
<(C) At least one polyhydric alcohol selected from glycerin, 1,3-butylene glycol, and propylene glycol>
The polyhydric alcohol as the component (C) is mainly contained to improve the foam quality and feel after cleansing.

 前記(C)成分の多価アルコールは、グリセリン、1,3-ブチレングリコール、及びプロピレングリコールから選択される少なくとも1種である。 The polyhydric alcohol of component (C) is at least one selected from glycerin, 1,3-butylene glycol, and propylene glycol.

 前記(C)成分の多価アルコールは、適宜合成したものを使用してもよく、市販品を使用してもよい。
 前記(C)成分の多価アルコールとしてのグリセリンの市販品としては、例えば、商品名で、ELOGLYN R995(グリセリン)(LG Household & Health Care製)、化粧品用濃グリセリン(ミヨシ油脂株式会社製)、トリオール VE(高級アルコール工業株式会社製)などが挙げられる。
As for the polyhydric alcohol of component (C), an appropriately synthesized one may be used, or a commercially available product may be used.
Commercially available products of glycerin as the polyhydric alcohol of component (C) include, for example, ELOGLYN R995 (glycerin) (manufactured by LG Household & Health Care), concentrated glycerin for cosmetics (manufactured by Miyoshi Oil Co., Ltd.), Triol VE (manufactured by KOKYU ALCOHOL KOGYO Co., Ltd.) and the like.

 前記(C)成分の多価アルコールとしての1,3-ブチレングリコールの市販品としては、例えば、商品名で、ハイシュガーケイン BG(高級アルコール工業株式会社製)などが挙げられる。 Commercially available products of 1,3-butylene glycol as the polyhydric alcohol of component (C) include, for example, High Sugar Cane BG (manufactured by Kokyu Alcohol Kogyo Co., Ltd.) under the trade name.

 前記(C)成分の多価アルコールとしてのプロピレングリコールの市販品としては、例えば、商品名で、化粧用プロピレングリコール(ADEKA製)、Propylene Glycol JSQI(ダウ・ケミカル製)などが挙げられる。 Commercial products of propylene glycol as the polyhydric alcohol of component (C) include, for example, cosmetic propylene glycol (manufactured by ADEKA) and Propylene Glycol JSQI (manufactured by Dow Chemical).

 前記(C)成分の多価アルコールの含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、泡質及び洗浄後の感触の点から、前記皮膚洗浄剤組成物全量に対して、3質量%~12質量%が好ましく、5質量%~10質量%がより好ましい。前記(C)成分の含有量が、3質量%以上であると、泡質及び洗浄後の感触が良好であり、12質量%以下であると、泡質及び洗浄後の感触が良好である。 The content of the polyhydric alcohol of component (C) is not particularly limited and can be appropriately selected according to the purpose. 3% by mass to 12% by mass, more preferably 5% by mass to 10% by mass. When the content of component (C) is 3% by mass or more, the foam quality and feel after washing are good, and when it is 12% by mass or less, the foam quality and feel after washing are good.

<質量比[(C)/(B)]>
 前記(B)成分の含有量(質量%)に対する前記(C)成分の含有量(質量%)の質量比[(C)/(B)]としては、大腸菌に対する殺菌力が高く、表皮ブドウ球菌(皮膚常在菌)に対する殺菌力が低い点から、3~30であり、5~25が好ましい。前記質量比[(C)/(B)]が、3未満又は30を超えると、大腸菌に対する殺菌力が低下する。
<Mass ratio [(C)/(B)]>
The mass ratio [(C)/(B)] of the content (% by mass) of the component (C) to the content (% by mass) of the component (B) has a high bactericidal activity against Escherichia coli and Staphylococcus epidermidis It is 3 to 30, preferably 5 to 25, because of its low bactericidal activity against (indigenous skin bacteria). When the mass ratio [(C)/(B)] is less than 3 or more than 30, the bactericidal activity against E. coli is lowered.

<(D)両性界面活性剤>
 前記(D)成分としての両性界面活性剤は、主に、泡質を向上させるために含有される。
<(D) amphoteric surfactant>
The amphoteric surfactant as component (D) is mainly contained to improve foam quality.

 前記両性界面活性剤としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、アルキルベタイン型両性界面活性剤、アミドベタイン型両性界面活性剤、スルホベタイン型両性界面活性剤、ヒドロキシスルホベタイン型両性界面活性剤、アミドスルホベタイン型両性界面活性剤、ホスホベタイン型両性界面活性剤、イミダゾリン型両性界面活性剤、アミンオキシド型両性界面活性剤などが挙げられる。これらは、1種単独で使用してもよく、2種以上を併用してもよい。 The amphoteric surfactant is not particularly limited and can be appropriately selected depending on the intended purpose. Hydroxysulfobetaine type amphoteric surfactants, amidosulfobetaine type amphoteric surfactants, phosphobetaine type amphoteric surfactants, imidazoline type amphoteric surfactants, amine oxide type amphoteric surfactants and the like. These may be used individually by 1 type, and may use 2 or more types together.

 前記アルキルベタイン型両性界面活性剤としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ラウリルジメチルアミノ酢酸ベタイン、ラウリルベタインなどが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。 The alkylbetaine-type amphoteric surfactant is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include betaine lauryldimethylaminoacetate and laurylbetaine. These may be used individually by 1 type, and may use 2 or more types together.

 前記アミドベタイン型両性界面活性剤としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ラウリン酸アミドプロピルベタイン(ラウラミドプロピルベタイン)、ステアリルジメチルアミノ酢酸ベタイン、コカミドプロピルベタイン(ヤシ油脂肪酸アミドプロピルベタイン)などが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。 The amidobetaine-type amphoteric surfactant is not particularly limited and can be appropriately selected depending on the intended purpose. betaine (coconut oil fatty acid amidopropyl betaine) and the like. These may be used individually by 1 type, and may use 2 or more types together.

 前記スルホベタイン型両性界面活性剤としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ヤシ油脂肪酸ジメチルスルホプロピルベタインなどが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。 The sulfobetaine-type amphoteric surfactant is not particularly limited and can be appropriately selected according to the purpose. Examples thereof include coconut oil fatty acid dimethylsulfopropylbetaine. These may be used individually by 1 type, and may use 2 or more types together.

 前記ヒドロキシスルホベタイン型両性界面活性剤としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ラウリルヒドロキシスルタインなどが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。 The hydroxysulfobetaine-type amphoteric surfactant is not particularly limited and can be appropriately selected depending on the purpose. Examples include lauryl hydroxysultaine. These may be used individually by 1 type, and may use 2 or more types together.

 前記アミドスルホベタイン型両性界面活性剤としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、コカミドプロピルヒドロキシスルタイン、ラウラミドプロピルヒドロキシスルタインなどが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。 The amidosulfobetaine-type amphoteric surfactant is not particularly limited and can be appropriately selected according to the purpose. Examples thereof include cocamidopropyl hydroxysultaine and lauramidopropyl hydroxysultaine. These may be used individually by 1 type, and may use 2 or more types together.

 前記ホスホベタイン型両性界面活性剤としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ラウリルヒドロキシホスホベタインなどが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。 The phosphobetaine-type amphoteric surfactant is not particularly limited and can be appropriately selected depending on the purpose. Examples include lauryl hydroxyphosphobetaine. These may be used individually by 1 type, and may use 2 or more types together.

 前記イミダゾリン型両性界面活性剤としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ヤシ油アルキル-N-ヒドロキシエチルイミダゾリニウムベタイン、2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタインなどが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。 The imidazoline type amphoteric surfactant is not particularly limited and can be appropriately selected depending on the intended purpose. and N-hydroxyethylimidazolinium betaine. These may be used individually by 1 type, and may use 2 or more types together.

 前記アミンオキシド型両性界面活性剤としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ラウリルジメチルアミンオキシド、ヤシ油アルキルジメチルアミンオキシドなどが挙げられる。これらは、1種単独で使用してもよいし、2種以上を併用してもよい。 The amine oxide type amphoteric surfactant is not particularly limited and can be appropriately selected according to the purpose. Examples thereof include lauryl dimethylamine oxide and coconut oil alkyldimethylamine oxide. These may be used individually by 1 type, and may use 2 or more types together.

 前記(D)成分の両性界面活性剤は、適宜合成したものを使用してもよく、市販品を使用してもよい。
 前記(D)成分の両性界面活性剤の市販品としては、例えば、商品名で、NIKKOL AM-3130N(コカミドプロピルベタイン、日光ケミカルズ株式会社製)、TEGO Betain(コカミドプロピルベタイン、Evonik社製)、アンヒトール 20AB(ラウリン酸アミドプロピルベタイン、花王株式会社製)、MITAINE L(ラウリルベタイン、Miwon Commercial社製)、アンホレックスLSB(ラウリルヒドロキシスルタイン、ミヨシ油脂株式会社)、アンヒトール 20HD(ラウリルヒドロキシスルタイン、花王株式会社製)、ソフタゾリン LSB(ラウラミドプロピルヒドロキシスルタイン、川研ファインケミカルズ株式会社)、ソフタゾリン CH(2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン、川研ファインケミカルズ株式会社)、アンヒトール20N(ラウリルジメチルアミンオキシド、花王株式会社製)、ユニセーフ(登録商標)A-LM(ラウリルジメチルアミンオキシド、日油株式会社製)などが挙げられる。
The amphoteric surfactant of component (D) may be appropriately synthesized or commercially available.
Examples of commercially available amphoteric surfactants of component (D) include NIKKOL AM-3130N (cocamidopropyl betaine, manufactured by Nikko Chemicals Co., Ltd.), TEGO Betain (cocamidopropyl betaine, manufactured by Evonik), and the like. ), Amphitol 20AB (lauryl amide propyl betaine, manufactured by Kao Corporation), MITAINE L (lauryl betaine, manufactured by Miwon Commercial), Ampholex LSB (lauryl hydroxysultaine, Miyoshi Oil Co., Ltd.), Amphithol 20HD (lauryl hydroxysultaine Tyne, manufactured by Kao Corporation), Softazoline LSB (lauramidopropyl hydroxysultaine, Kawaken Fine Chemicals Co., Ltd.), Softazoline CH (2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, Kawaken Fine Chemicals Co., Ltd.) company), Amphitol 20N (lauryl dimethylamine oxide, manufactured by Kao Corporation), Unisafe (registered trademark) A-LM (lauryl dimethylamine oxide, manufactured by NOF Corporation), and the like.

 前記(D)成分の両性界面活性剤の含有量としては、特に制限はなく、目的に応じて適宜選択することができるが、泡質及び手肌への刺激のなさの点から、前記皮膚洗浄剤組成物全量に対して、0.1質量%~5質量%が好ましく、0.5質量%~4質量%がより好ましい。前記(D)成分の含有量が、0.1質量%以上であると、泡質が良好であり、5質量%以下であると、手肌への刺激のなさが良好である。 The content of the amphoteric surfactant as component (D) is not particularly limited and can be appropriately selected according to the purpose. It is preferably 0.1% by mass to 5% by mass, more preferably 0.5% by mass to 4% by mass, based on the total amount of the agent composition. When the content of the component (D) is 0.1% by mass or more, the foam quality is good, and when it is 5% by mass or less, the hand skin is not irritated.

<その他の成分>
 本発明の皮膚洗浄剤組成物には、前記(A)成分、前記(B)成分、前記(C)成分、及び前記(D)成分の各成分以外にも、本発明を損なわない範囲で、必要に応じて、皮膚洗浄剤組成物などに通常用いられる成分をその他の成分として配合することができる。
<Other ingredients>
In the skin cleanser composition of the present invention, in addition to the components (A), (B), (C), and (D), the following components are included within the scope of the present invention: Ingredients commonly used in skin cleansing compositions and the like can be blended as other ingredients, if desired.

 前記その他の成分としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、シリコーン類、保湿剤、前記(A)成分以外のアニオン性界面活性剤(例えば、ポリオキシエチレンアルキルエーテル硫酸ナトリウム等)、ノニオン性界面活性剤(例えば、ポリオキシエチレンアルキルエーテル等)、カチオン性界面活性剤(例えば、塩化ステアリルトリメチルアンモニウム等)、抗炎症剤(例えば、グリチルリチン酸ジカリウム、グリチルレチン酸、アラントイン等)、ビタミン類、カチオン性ポリマー(例えば、カチオン化セルロース、カチオン化グアーガム、ポリ塩化ジメチルジメチレンピロリジニウム(ポリクオタニウム-6)、塩化ジメチルジアリルアンモニウム・アクリルアミド共重合体等)、両性ポリマー(例えば、アクリル酸/ジメチルジアリルアンモニウム共重合体等)、アニオン性ポリマー(例えば、アクリル酸系ポリマー等)、動物抽出エキス又はその誘導体、前記(B)成分以外の植物抽出エキス又はその誘導体、パール化剤、着色剤、スクラブ剤(例えば、ポリエチレン等)、香料、色素、顔料、前記(B)成分以外の防腐剤(例えば、メチルパラベン、フェノキシエタノール等)、糖類、油分、ラノリン誘導体、蛋白誘導体、アクリル樹脂分散液、酸化防止剤、金属封鎖剤、紫外線吸収剤、湿潤剤(例えば、ソルビトール等)、乳化剤(例えば、ステアレス-11、トリデセス-8、オクチルドデセス-5等)、キレート剤(例えば、EDTA-4Na等)、pH調整剤(例えば、水酸化カリウム、モノエタノールアミン等)、溶媒(例えば、水等)などが挙げられる。 The other components are not particularly limited and can be appropriately selected depending on the intended purpose. Examples include silicones, moisturizing agents, anionic surfactants other than the component (A) sodium ether sulfate, etc.), nonionic surfactants (e.g., polyoxyethylene alkyl ethers, etc.), cationic surfactants (e.g., stearyltrimethylammonium chloride, etc.), anti-inflammatory agents (e.g., dipotassium glycyrrhizinate, glycyrrhetinic acid, allantoin, etc.), vitamins, cationic polymers (e.g., cationized cellulose, cationized guar gum, polydimethyldimethylethylenepyrrolidinium chloride (polyquaternium-6), dimethyldiallylammonium chloride/acrylamide copolymer, etc.), amphoteric polymers ( acrylic acid/dimethyldiallylammonium copolymer, etc.), anionic polymers (e.g., acrylic acid-based polymers, etc.), animal extracts or derivatives thereof, plant extracts other than the component (B) or derivatives thereof, pearlization agents, coloring agents, scrubbing agents (e.g. polyethylene, etc.), fragrances, dyes, pigments, preservatives other than the component (B) (e.g., methylparaben, phenoxyethanol, etc.), sugars, oils, lanolin derivatives, protein derivatives, acrylic resins Dispersion liquid, antioxidant, sequestering agent, ultraviolet absorber, wetting agent (e.g., sorbitol, etc.), emulsifier (e.g., steareth-11, trideceth-8, octyldodeceth-5, etc.), chelating agent (e.g., EDTA-4Na etc.), pH adjusters (eg, potassium hydroxide, monoethanolamine, etc.), solvents (eg, water, etc.), and the like.

-pH-
 前記皮膚洗浄剤組成物の25℃におけるpHとしては、特に制限はなく、目的に応じて適宜選択することができるが、8.0~12.0が好ましく、8.5~11.0がより好ましい。
 前記pHは、例えば、pHメーター(東亜ディーケーケー株式会社製、HM-30V)を使用して測定することができる。
-pH-
The pH of the skin cleanser composition at 25° C. is not particularly limited and can be appropriately selected depending on the intended purpose. preferable.
The pH can be measured, for example, using a pH meter (HM-30V manufactured by Toa DKK Co., Ltd.).

-容器-
 本発明の皮膚洗浄剤組成物は、特に制限はなく、通常の容器に充填して使用される。
 前記容器としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、ポンプディスペンサー容器、チューブ容器、フォーマー容器、スクイズ容器、袋状容器などが挙げられる。これらの中でも、フォーマー容器が好ましい。
-container-
The skin cleanser composition of the present invention is not particularly limited, and is used by being filled in a normal container.
The container is not particularly limited and can be appropriately selected depending on the intended purpose. Examples thereof include a pump dispenser container, a tube container, a foamer container, a squeeze container, and a bag-like container. Among these, a former container is preferable.

 前記フォーマー容器としては、特に制限はなく、公知のフォーマー容器の中から適宜選択することができ、例えば、ノンガス型の泡吐出容器、噴射剤と耐圧容器を使用したエアゾール容器などが挙げられる。これらの中でも、ノンガス型の泡吐出容器が好ましい。 The foamer container is not particularly limited and can be appropriately selected from known foamer containers. Examples thereof include a non-gas type foam discharge container, an aerosol container using a propellant and a pressure container, and the like. Among these, a non-gas foam discharge container is preferable.

 前記ノンガス型の泡吐出容器としては、前記皮膚洗浄剤組成物を空気と混合して発泡状態で吐出できるものであれば、特に制限はなく、目的に応じて適宜選択することができ、例えば、ボトル胴部を手で圧搾することによって泡を吐出できるスクイズフォーマー容器、ノズル部を押し下げることによって泡を吐出できるポンプフォーマー容器などが挙げられる。このようなフォーマー容器は、大和製罐株式会社製、株式会社吉野工業所製等のものを使用することができる。より具体的には、フォーマー容器としては、特開平7-315463号公報、特開平8-230961号公報、及び特開2005-193972号公報に記載されたフォーマー容器などを使用することができる。 The non-gas type foam discharge container is not particularly limited as long as it can mix the skin cleanser composition with air and discharge it in a foamed state, and can be appropriately selected according to the purpose. A squeeze foamer container capable of discharging foam by squeezing the body of the bottle by hand, and a pump foaming container capable of discharging foam by pushing down the nozzle portion may be used. As such a former container, those manufactured by Yamato Seikan Co., Ltd., Yoshino Kogyosho Co., Ltd., or the like can be used. More specifically, as the former container, the former containers described in JP-A-7-315463, JP-A-8-230961, and JP-A-2005-193972 can be used.

 前記ノンガス型の泡吐出容器は、通常、泡を形成するための泡形成部材を有する。
 前記ノンガス型の泡吐出容器の具体例としては、多孔質膜体(材質は、ナイロン、ポリエステル、ポリオレフィン等のプラスチック材料が好ましい)を有し、前記皮膚洗浄剤組成物が該多孔質膜体を通過することにより泡が形成されるものなどが挙げられる。
The non-gas type foam dispenser usually has a foam forming member for forming foam.
A specific example of the non-gas type foam discharge container has a porous membrane (preferably made of a plastic material such as nylon, polyester, or polyolefin), and the skin cleanser composition is applied to the porous membrane. Examples include those that form bubbles upon passage.

 前記多孔質膜体のメッシュとしては、特に制限はなく、目的に応じて適宜選択することができるが、100メッシュ以上が好ましく、100メッシュ~400メッシュがより好ましく、200メッシュ~305メッシュが特に好ましい。
 また、前記多孔質膜体の枚数としては、特に制限はなく、目的に応じて適宜選択することができるが、泡性能を向上させる観点から、2枚~4枚が好ましい。
The mesh of the porous membrane is not particularly limited and can be appropriately selected depending on the purpose. .
The number of the porous membranes is not particularly limited and can be appropriately selected depending on the purpose, but from the viewpoint of improving foam performance, 2 to 4 are preferable.

-性状-
 前記皮膚洗浄剤組成物の性状としては、特に制限はなく、目的に応じて適宜選定することができるが、常温で液体状が好ましい。
 前記皮膚洗浄剤組成物の25℃における粘度としては、特に制限はなく、目的に応じて適宜選択することができるが、1mPa・s~30mPa・sが好ましく、3mPa・s~30mPa・sがより好ましい。前記粘度が、1mPa・s以上又は30mPa・s以下であると、泡質が良好である。
 また、フォーマー容器を使用する際、例えば、ノズル部を押し下げることによって泡を吐出できるポンプフォーマー容器と、200メッシュの多孔質膜体を2枚使用する際において、使用する温度条件下で皮膚洗浄剤組成物の粘度は、15mPa・s以下が好ましく、1mPa・s~10mPa・sがより好ましい。
 ここで、前記粘度は、例えば、B型粘度計を用いて、前記皮膚洗浄剤組成物の温度を25℃とし、転数60回転/分間、No.1のローターにて1分間後の粘度を測定することにより測定できる。
-Properties-
The properties of the skin cleanser composition are not particularly limited and can be appropriately selected depending on the intended purpose, but liquid form at room temperature is preferable.
The viscosity of the skin cleanser composition at 25° C. is not particularly limited and can be appropriately selected depending on the intended purpose. preferable. Foam quality is favorable in the said viscosity being 1 mPa*s or more or 30 mPa*s or less.
Also, when using a foamer container, for example, when using a pump foamer container that can discharge foam by pushing down the nozzle part and two 200-mesh porous membranes, the skin is washed under the temperature conditions used. The viscosity of the agent composition is preferably 15 mPa·s or less, more preferably 1 mPa·s to 10 mPa·s.
Here, the viscosity is determined, for example, by using a Brookfield viscometer, setting the temperature of the skin cleanser composition to 25° C., rotating at 60 rotations/minute, No. It can be measured by measuring the viscosity after 1 minute with No. 1 rotor.

-製造方法-
 本発明の皮膚洗浄剤組成物の製造方法としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、前記(A)、前記(B)成分、前記(C)成分、及び前記(D)成分、更に必要に応じて、前記その他の成分、及び前記精製水(前記皮膚洗浄剤組成物全体が100質量%となるように残量として配合)を混合して得ることができる。混合する際、必要に応じて加温してもよい。
-Production method-
The method for producing the skin cleanser composition of the present invention is not particularly limited and can be appropriately selected according to the purpose. It can be obtained by mixing the component (D), optionally the other components, and the purified water (blended as the remaining amount so that the entire skin cleanser composition is 100% by mass). . When mixing, you may heat as needed.

 前記皮膚洗浄剤組成物は、装置を用いて調製してもよい。前記装置としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、剪断力があり、全体を混合することができる攪拌羽根を備えた攪拌装置などが挙げられる。
 前記攪拌羽根としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、プロペラ、タービン、ディスパーなどが挙げられる。
The skin cleanser composition may be prepared using an apparatus. The device is not particularly limited and can be appropriately selected depending on the intended purpose.
The stirring blade is not particularly limited and can be appropriately selected depending on the purpose. Examples thereof include propellers, turbines, and dispersers.

-用途-
 前記皮膚洗浄剤組成物の使用部位としては、特に制限はなく、目的に応じて適宜選択することができ、例えば、全身、顔、手などに使用することができる。
 前記皮膚洗浄剤組成物の使用方法としては、特に制限はなく、目的に応じて適宜選択することができるが、フォーマー容器に充填し、泡状に吐出して使用することが好ましい。
-Applications-
The application site of the skin cleanser composition is not particularly limited and can be appropriately selected according to the intended purpose.
The method of using the skin cleanser composition is not particularly limited and can be appropriately selected according to the intended purpose.

 前記皮膚洗浄剤組成物は、皮膚上のバリア機能を高める常在菌は保持しながら、病原性を持つ大腸菌等に対しては高い殺菌力を有し、着色がなく液外観が良好であり、嫌味臭がなく、泡質、洗浄後の感触、手肌への刺激のなさ、及び安定性に優れるため、例えば、ボディシャンプー、ボディソープ、洗顔フォーム、液体ハンドソープ、泡ハンドソープ、クレンジングフォーム、メイク落としなどに用いることができ、特に泡状で吐出される液体ハンドソープに好適に用いることができる。 The skin cleanser composition retains the indigenous bacteria that enhance the barrier function on the skin, has high bactericidal activity against pathogenic E. coli and the like, and has a good liquid appearance without coloration. It has no unpleasant odor, excellent foam quality, feel after washing, no irritation to hands and skin, and excellent stability. It can be used for makeup removal and the like, and can be particularly suitably used for liquid hand soap that is discharged in foam form.

 以下に実施例、比較例、及び処方例を挙げて本発明を具体的に説明するが、本発明はこれらの実施例及び処方例に何ら限定されるものではない。 The present invention will be specifically described below with reference to Examples, Comparative Examples, and Formulation Examples, but the present invention is not limited to these Examples and Formulation Examples.

 実施例、比較例、及び処方例に記載の各成分の含有量は質量%で示し、全て純分換算した値である。また、(B)成分の含有量(質量%)に対する(C)成分の含有量(質量%)の質量比[(C)/(B)]は、小数点以下第2位を四捨五入し、小数点以下第1位まで求め、記載した。 The content of each component described in Examples, Comparative Examples, and Formulation Examples is shown in mass%, and all values are converted to pure content. In addition, the mass ratio [(C)/(B)] of the content (% by mass) of component (C) to the content (% by mass) of component (B) is rounded to the second decimal place, We asked for the first place and listed it.

(実施例1~32及び比較例1~12)
<皮膚洗浄剤組成物の調製>
 70℃~80℃において、下記表1~表6に示す組成及び含有量(質量%)の(A)成分、(C)成分、及び(D)成分と、精製水と、共通成分とを均一に溶解させた。その後、40℃以下に冷却してから、(B)成分又は(B)成分の比較成分を添加し、均一になるまで撹拌し、溶解液を得た。次いで、前記溶解液を撹拌しながら適宜水酸化カリウムを加え、所定のpHに調整した。その後、各溶解液の全体量が100質量%になるように精製水を加え、実施例1~32及び比較例1~12の皮膚洗浄剤組成物を得た。
 なお、下記表9に示す通り、(B)成分の「ハッカ油」は水蒸気蒸留抽出法により得られた抽出物であり、(B)成分の「チシマザサ水」は圧搾抽出法により得られた抽出物であり、(B)成分の比較成分は、ブチレングリコール又はエタノールを抽出溶媒として用いた溶剤抽出物である。
(Examples 1 to 32 and Comparative Examples 1 to 12)
<Preparation of skin cleanser composition>
At 70 ° C. to 80 ° C., the components (A), (C), and (D) having the compositions and contents (% by mass) shown in Tables 1 to 6 below, purified water, and common components were uniformly mixed. was dissolved in Thereafter, after cooling to 40° C. or less, the component (B) or a comparative component of the component (B) was added and stirred until uniform to obtain a solution. Next, while stirring the solution, potassium hydroxide was appropriately added to adjust the pH to a predetermined value. After that, purified water was added so that the total amount of each solution was 100% by mass, and skin cleansing compositions of Examples 1 to 32 and Comparative Examples 1 to 12 were obtained.
In addition, as shown in Table 9 below, the component (B) "mint oil" is an extract obtained by a steam distillation extraction method, and the component (B) "Chishima Sasa water" is an extract obtained by a compression extraction method. The comparative component of component (B) is a solvent extract using butylene glycol or ethanol as an extraction solvent.

 実施例1~32及び比較例1~12の各皮膚洗浄剤組成物について、以下のようにして、「大腸菌に対する殺菌力」、「液外観」、「臭い」、「泡質」(泡の弾力性、泡のクリーミーさ、及び泡の持続性)、「洗浄後の感触」(すすぎ後のさっぱり感及びすすぎ後のしっとり感)、「手肌への刺激のなさ」、及び「安定性」(低温安定性、高温安定性、及びpH)を評価及び判定した。また、実施例1~32の各皮膚洗浄剤組成物について、以下のようにして、更に「表皮ブドウ球菌に対する殺菌力」を評価及び判定した。結果を下記表1~表6に示した。 For each of the skin cleansing compositions of Examples 1 to 32 and Comparative Examples 1 to 12, "bactericidal activity against Escherichia coli", "liquid appearance", "odor", "foam quality" (elasticity of foam) was determined as follows. , creaminess of foam, and persistence of foam), “feel after washing” (refreshing feeling after rinsing and moist feeling after rinsing), “non-irritation to hand skin”, and “stability” ( Low temperature stability, high temperature stability, and pH) were evaluated and determined. In addition, each of the skin cleanser compositions of Examples 1 to 32 was further evaluated and determined for "bactericidal activity against Staphylococcus epidermidis" as follows. The results are shown in Tables 1 to 6 below.

<大腸菌に対する殺菌力>
(1)菌液の調製
 感染症を引き起こす代表的な大腸菌(Escherichia coli NBRC3972:グラム陰性菌、独立行政法人製品評価技術基盤機構より入手)を、SCDLP培地(日本製薬株式会社製)を用いて、好気条件下で30℃にて24時間静置培養した。次に、前記大腸菌を生理食塩水(大塚製薬株式会社製)に懸濁させ、初発菌数が10細胞個/mLとなるように調整し、菌液を調製した。
<Bactericidal power against E. coli>
(1) Preparation of bacterial solution A representative Escherichia coli that causes infectious diseases ( Escherichia coli NBRC3972: Gram-negative bacteria, obtained from the National Institute of Technology and Evaluation) was prepared using SCDLP medium (manufactured by Nihon Pharmaceutical Co., Ltd.). Static culture was carried out at 30° C. for 24 hours under aerobic conditions. Next, the Escherichia coli was suspended in physiological saline (manufactured by Otsuka Pharmaceutical Co., Ltd.), and the number of initial bacteria was adjusted to 10 6 cells/mL to prepare a bacterial solution.

(2)試験液の調製
 実施例1~32及び比較例1~12の各皮膚洗浄剤組成物を滅菌水で10倍希釈し、各試験液を調製した。
(2) Preparation of Test Solution Each skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 12 was diluted 10-fold with sterilized water to prepare each test solution.

(3)評価方法
 25℃にて、前記(2)で得られた各試験液10mLに、前記(1)で得られた菌液0.1mLを添加して十分撹拌し、前記(1)の添加から30秒間後に混合液0.3mLを取り出し、2.7mLのSCDLP寒天培地(Soybean-Casein Digest Broth with Lectin & Polysorbate 80、和光純薬工業株式会社製)に加え、10倍希釈液を得た。同様の方法を繰り返し、菌液の10倍、10倍、及び10倍の各希釈液を得た。各希釈液から1.0mLをシャーレに採取し、SCDLP寒天培地15mLを加えて均一化し、30℃にて1日間培養した後、コロニー数をカウントして生存菌数を測定した(寒天平板希釈法)。下記式(1)により初発菌数と、生存菌数との差(Δlog10)を算出し、下記判定基準に基づき「大腸菌に対する殺菌力」を判定した。なお、下記式(1)により算出される数値が大きいほど殺菌力が高いことを表す。
  殺菌数Δlog10=-log10(生存菌数/初発菌数) ・・・式(1)
-「大腸菌に対する殺菌力」の判定基準-
 ◎ : Δlog10が、2.7以上
 ○ : Δlog10が、2.5以上2.7未満
 △ : Δlog10が、2.0以上2.5未満
 × : Δlog10が、2.0未満
(3) Evaluation method At 25 ° C., 0.1 mL of the bacterial solution obtained in (1) was added to 10 mL of each test solution obtained in (2) above, and the mixture was sufficiently stirred. 30 seconds after the addition, 0.3 mL of the mixed solution was taken out and added to 2.7 mL of SCDLP agar medium (Soybean-Casein Digest Broth with Lectin & Polysorbate 80, manufactured by Wako Pure Chemical Industries, Ltd.) to obtain a 10-fold diluted solution. . A similar method was repeated to obtain 10 2 -fold, 10 3 -fold, and 10 4 -fold dilutions of the bacterial solution. 1.0 mL of each diluted solution was collected in a petri dish, homogenized by adding 15 mL of SCDLP agar medium, cultured at 30 ° C. for 1 day, and the number of surviving bacteria was measured by counting the number of colonies (agar plate dilution method ). The difference (Δlog 10 ) between the number of initial bacteria and the number of surviving bacteria was calculated by the following formula (1), and the "bactericidal activity against Escherichia coli" was determined based on the criteria below. In addition, it represents that the larger the numerical value calculated by the following formula (1), the higher the bactericidal activity.
Sterilization number Δlog 10 = -log 10 (number of surviving bacteria/number of initial bacteria) Formula (1)
-Judgment criteria for “Bactericidal activity against Escherichia coli”-
◎: Δlog 10 is 2.7 or more ○: Δlog 10 is 2.5 or more and less than 2.7 △: Δlog 10 is 2.0 or more and less than 2.5 ×: Δlog 10 is less than 2.0

<液外観>
 実施例1~32及び比較例1~12の調製直後の各皮膚洗浄剤組成物50gを硬質ガラスのバイアル瓶に充填し、専門パネル1名が液外観を目視にて観察し、下記判定基準に基づき「液外観」を判定した。
-「液外観」の判定基準-
 ◎ : 液色が透明
 ○ : 液色がわずかに黄色を呈している
 △ : 液色が黄色を呈している
 × : 液色が褐色を呈している
<Liquid Appearance>
50 g of each of the skin cleansing compositions of Examples 1 to 32 and Comparative Examples 1 to 12 immediately after preparation was filled into a hard glass vial bottle, and the appearance of the liquid was visually observed by a panel of experts. "Liquid appearance" was determined based on the results.
- Judgment criteria for "liquid appearance" -
◎: The liquid color is transparent ○: The liquid color is slightly yellow △: The liquid color is yellow ×: The liquid color is brown

<臭い>
 実施例1~32及び比較例1~12の調製直後の各皮膚洗浄剤組成物50gを硬質ガラスのバイアル瓶に充填し、専門パネル3名が下記判定基準に基づき「臭い」を評価した。結果は、専門パネル3名の平均評価点を求め、下記判定基準に基づき判定した。
-「臭い」の評価基準-
 5 : 特異的な臭いが全くない
 4 : 特異的な臭いをわずかに感じる
 3 : 特異的な臭いをやや感じる
 2 : 特異的な臭いをかなり感じるが嫌味臭はない
 1 : 特異的な臭いを強く感じ嫌味臭である
-「臭い」の判定基準-
 ◎ : 平均評価点が4.0点以上
 ○ : 平均評価点が3.0点以上4.0点未満
 △ : 平均評価点が2.0点以上3.0点未満
 × : 平均評価点が2.0点未満
<Smell>
50 g of each of the skin cleanser compositions of Examples 1 to 32 and Comparative Examples 1 to 12 immediately after preparation was filled into a hard glass vial bottle, and three expert panels evaluated the "smell" based on the following criteria. The results were evaluated based on the following evaluation criteria by calculating the average score of 3 expert panelists.
-Evaluation Criteria for “Smell”-
5: No specific odor at all 4: Slight specific odor 3: Slightly specific odor 2: Significant specific odor but no offensive odor 1: Strong specific odor Feeling unpleasant odor - Criteria for "smell" -
◎: Average score of 4.0 or more ○: Average score of 3.0 or more and less than 4.0 △: Average score of 2.0 or more and less than 3.0 ×: Average score of 2 Less than 0 points

<泡質>
 実施例1~32及び比較例1~12の各皮膚洗浄剤組成物をフォーマー容器(株式会社吉野工業所製)に充填した。専門パネル3名が、前記容器に充填した実施例1~32及び比較例1~12の各皮膚洗浄剤組成物の(1)「泡の弾力性」、(2)「泡のクリーミーさ」、及び(3)「泡の持続性」を以下の方法で評価し、3名の専門パネルの平均評価点をそれぞれの項目で算出し、3項目の平均評価点の合計点を求め、下記判定基準に基づき「泡質」を判定した。
-「泡質」の判定基準-
 ◎ : (1)~(3)の平均評価点の合計点が12.0点以上、かつ(1)~(3)の全項目の平均評価点が4点以上
 ○ : (1)~(3)の平均評価点の合計点が9.0点以上12.0点未満、かつ(1)~(3)の全項目の平均評価点が3点以上
 △ : (1)~(3)の平均評価点の合計点が6.0点以上9.0点未満、かつ(1)~(3)の全項目の平均評価点が全項目2点以上
 × : (1)~(3)の平均評価点の合計点が6.0点未満
<Foam Quality>
Each skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 12 was filled in a foamer container (manufactured by Yoshino Kogyosho Co., Ltd.). Three expert panels evaluated (1) "elasticity of foam", (2) "creaminess of foam" of each of the skin cleanser compositions of Examples 1 to 32 and Comparative Examples 1 to 12 filled in the container. And (3) "foam persistence" was evaluated by the following method, the average score of the three expert panels was calculated for each item, and the total score of the average score of the three items was calculated, and the following judgment criteria were obtained. "Foam quality" was determined based on.
- Judgment criteria for "foam quality" -
◎: The total score of the average evaluation points of (1) to (3) is 12.0 points or more, and the average evaluation score of all items (1) to (3) is 4 points or more ○: (1) to (3) ) has a total score of 9.0 or more and less than 12.0 points, and the average score of all items (1) to (3) is 3 points or more △: Average of (1) to (3) The total evaluation score is 6.0 or more and less than 9.0 points, and the average evaluation score of all items (1) to (3) is 2 points or more ×: Average evaluation of (1) to (3) The total score is less than 6.0 points

(1)泡の弾力性
 専門パネル3名が、両手を水で濡らし、一度両手を振って水気を軽くとった右手の平に、実施例1~32及び比較例1~12の各皮膚洗浄剤組成物1g(1プッシュ)を25℃の条件において、フォーマー容器から吐出させた。両手の手の平を合わせて往復させるように手の平を擦り、両手を10往復させた後、右手の手の平に集めた泡に左手を押し付け、「泡の弾力性」を下記評価基準に基づき評価した。
-「泡の弾力性」の評価基準-
 5点 : 泡の弾力性が非常にある
 4点 : 泡の弾力性がある
 3点 : 泡の弾力性がややある
 2点 : 泡の弾力性がややない
 1点 : 泡の弾力性がほとんどない
(1) Elasticity of Foam Three expert panelists moistened both hands with water, waved them once to lightly dry the water, and applied each of the skin cleanser compositions of Examples 1 to 32 and Comparative Examples 1 to 12 to the palm of the right hand. 1 g (1 push) of the product was discharged from the former container under the condition of 25°C. The palms of both hands were rubbed together and reciprocated, and after reciprocating both hands 10 times, the left hand was pressed against the foam collected in the right palm, and the "elasticity of the foam" was evaluated based on the following evaluation criteria.
-Evaluation Criteria for “Foam Elasticity”-
5 points: The foam is very elastic 4 points: The foam is elastic 3 points: The foam is somewhat elastic 2 points: The foam is slightly elastic 1 point: The foam is almost non-elastic

(2)泡のクリーミーさ
 専門パネル3名が、両手を水で濡らし、一度両手を振って水気を軽くとった右手の平に、実施例1~32及び比較例1~12の各皮膚洗浄剤組成物1g(1プッシュ)を25℃の条件において、フォーマー容器から吐出させた。両手の手の平を合わせて往復させるように手の平を擦り、両手を10往復させたときの泡の外観を目視にて観察し、またこのときの使用感から「泡のクリーミーさ」を下記評価基準に基づき評価した。
-「泡のクリーミーさ」の評価基準-
 5点 : ほとんどの泡が細かい泡で、非常にクリーミーであった
 4点 : 細かい泡の中の一部に大きな泡が混ざっているが、クリ-ミーであった
 3点 : 細かい泡の中に大きな泡が半分ぐらい混ざり、ややクリーミーであった
 2点 : 細かい泡よりも大きく粗い泡の方が多く、クリーミーではなかった
 1点 : 大きく粗い泡しか立たず、全くクリーミーではなかった
(2) Creaminess of foam Three expert panelists moistened both hands with water, waved them once to lightly dry the water, and applied each of the skin cleanser compositions of Examples 1 to 32 and Comparative Examples 1 to 12 to the palm of the right hand. 1 g (1 push) of the product was discharged from the former container under the condition of 25°C. The palms of both hands were rubbed together and reciprocated, and the appearance of the foam was visually observed when both hands were reciprocated 10 times. evaluated based on
-Evaluation Criteria for “Creamyness of Foam”-
5 points: Most of the bubbles were fine bubbles and were very creamy 4 points: Large bubbles were mixed in some of the fine bubbles, but they were creamy 3 points: Among the fine bubbles About half of the large bubbles were mixed, and it was slightly creamy. 2 points: There were more large and coarse bubbles than fine bubbles, and it was not creamy. 1 point: Only large and coarse bubbles were formed, and it was not creamy at all.

(3)泡の持続性
 専門パネル3名が、両手を水で濡らし、一度両手を振って水気を軽くとった右手の平に、実施例1~32及び比較例1~12の各皮膚洗浄剤組成物1g(1プッシュ)を25℃の条件において、フォーマー容器から吐出させた。両手の手の平を合わせて往復させるように手の平を擦り、両手を10往復させた後、10秒間静置した。両手を10往復擦り合わせた直後の泡量(Fa)、及び擦り合わせてから10秒間静置後の泡量(Fb)をそれぞれ目視にて観察し、「泡の持続性」を下記評価基準に基づき評価した。
-「泡のクリーミーさ」の評価基準-
 5点 : 泡量(Fa)と泡量(Fb)とで全く変化なし
 4点 : 泡量(Fa)と泡量(Fb)とでほぼ変化なし
 3点 : 泡量(Fa)と比べて泡量(Fb)が減少している
 2点 : 泡量(Fa)と比べて泡量(Fb)がかなり減少している
 1点 : 泡量(Fa)及び泡量(Fb)共に泡が手に残らない
(3) Sustainability of foam Three expert panelists moistened both hands with water, waved them once to lightly dry the water, and applied each of the skin cleanser compositions of Examples 1 to 32 and Comparative Examples 1 to 12 to the palm of the right hand. 1 g (1 push) of the product was discharged from the former container under the condition of 25°C. The palms of both hands were put together and the palms were rubbed in a reciprocating motion. The volume of foam (Fa) immediately after rubbing both hands back and forth 10 times and the volume of foam (Fb) after standing for 10 seconds after rubbing were visually observed, and the "sustainability of foam" was evaluated according to the following evaluation criteria. evaluated based on
-Evaluation Criteria for “Creamyness of Foam”-
5 points: no change at all between foam volume (Fa) and foam volume (Fb) 4 points: almost no change between foam volume (Fa) and foam volume (Fb) 3 points: foam compared to foam volume (Fa) 2 points: The foam volume (Fb) is much smaller than the foam volume (Fa). 1 point: Both the foam volume (Fa) and the foam volume (Fb) are does not remain

<洗浄後の感触>
 実施例1~32及び比較例1~12の各皮膚洗浄剤組成物をフォーマー容器(株式会社吉野工業所製)に充填した。専門パネル3名が、前記容器に充填した実施例1~32及び比較例1~12の各皮膚洗浄剤組成物の(1)「すすぎ後のさっぱり感」及び(2)「すすぎ後のしっとり感」を以下の方法で評価し、3名の専門パネルの平均評価点をそれぞれの項目で算出し、(1)及び(2)の平均評価点の合計点を求め、下記判定基準に基づき「洗浄後の感触」を判定した。
-「洗浄後の感触」の判定基準-
 ◎ : (1)及び(2)の平均評価点の合計点が8.0点以上
 ○ : (1)及び(2)の平均評価点の合計点が7.0点以上8.0点未満
 △ : (1)及び(2)の平均評価点の合計点が5.0点以上7.0点未満
 × : (1)及び(2)の平均評価点の合計点が5.0点未満
<Feeling after washing>
Each skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 12 was filled in a foamer container (manufactured by Yoshino Kogyosho Co., Ltd.). Three expert panels evaluated (1) "refreshing feeling after rinsing" and (2) "moist feeling after rinsing" of each of the skin cleanser compositions of Examples 1 to 32 and Comparative Examples 1 to 12 filled in the container. ”Evaluated by the following method, calculated the average score of the three specialized panels for each item, calculated the total score of the average scores of (1) and (2), and calculated the total score of the average scores of (1) and (2), Afterward feeling" was judged.
- Criteria for “feel after washing” -
◎: The total score of the average evaluation points of (1) and (2) is 8.0 points or more ○: The total score of the average evaluation points of (1) and (2) is 7.0 points or more and less than 8.0 points △ : The total score of the average evaluation points of (1) and (2) is 5.0 points or more and less than 7.0 points × : The total score of the average evaluation points of (1) and (2) is less than 5.0 points

(1)すすぎ後のさっぱり感
 専門パネル3名が、両手を水で濡らし、一度両手を振って水気を軽くとった右手の平に、実施例1~32及び比較例1~12の各皮膚洗浄剤組成物1g(1プッシュ)を25℃の条件において、フォーマー容器から吐出させた。両手の手の平を合わせて往復させるように手の平を擦り、両手を10秒間擦りあわせた後、水道水(25℃、2L/分間)で両手をすすぎ、各専門パネルがすすぎ終わったと判断した地点で、「すすぎ後のさっぱり感」を下記評価基準に基づき評価した。
-「すすぎ後のさっぱり感」の評価基準-
 5点 : さっぱり感が非常にある
 4点 : さっぱり感がある
 3点 : さっぱり感がややある
 2点 : さっぱり感がややない
 1点 : さっぱり感が全くない
(1) Refreshing feeling after rinsing Three expert panelists moistened both hands with water, waved them once to lightly dry them, and applied each of the skin cleansers of Examples 1 to 32 and Comparative Examples 1 to 12 to the palm of the right hand. 1 g (1 push) of the composition was discharged from a former container at 25°C. Rub the palms of both hands in a reciprocating motion, rub the palms together for 10 seconds, then rinse both hands with tap water (25 ° C, 2 L / min). "Refreshing feeling after rinsing" was evaluated based on the following evaluation criteria.
-Evaluation criteria for “refreshing feeling after rinsing”-
5 points: Very refreshing feeling 4 points: Refreshing feeling 3 points: Slightly refreshing feeling 2 points: Slightly not refreshing feeling 1 point: No refreshing feeling at all

(2)すすぎ後のしっとり感
 専門パネル3名が、両手を水で濡らし、一度両手を振って水気を軽くとった右手の平に、実施例1~32及び比較例1~12の各皮膚洗浄剤組成物1g(1プッシュ)を25℃の条件において、フォーマー容器から吐出させた。両手の手の平を合わせて往復させるように手の平を擦り、両手を10秒間擦りあわせた後、水道水(25℃、2L/分間)で両手をすすぎ、各専門パネルがすすぎ終わったと判断した地点で、「すすぎ後のしっとり感」を下記評価基準に基づき評価した。
-「すすぎ後のしっとり感」の評価基準-
 5点 : しっとり感が非常にある
 4点 : しっとり感がある
 3点 : しっとり感がややある
 2点 : しっとり感がややない
 1点 : しっとり感が全くない
(2) Moist feeling after rinsing Three expert panelists moistened both hands with water, waved them once to lightly dry the water, and applied each of the skin cleansers of Examples 1 to 32 and Comparative Examples 1 to 12 to the palm of the right hand. 1 g (1 push) of the composition was discharged from a former container at 25°C. Rub the palms of both hands in a reciprocating motion, rub the palms together for 10 seconds, then rinse both hands with tap water (25 ° C, 2 L / min). "Moist feeling after rinsing" was evaluated based on the following evaluation criteria.
-Evaluation criteria for “moist feeling after rinsing”-
5 points: very moist feeling 4 points: moist feeling 3 points: slightly moist feeling 2 points: slightly not moist feeling 1 point: no moist feeling at all

<手肌への刺激のなさ>
 実施例1~32及び比較例1~12の各皮膚洗浄剤組成物をフォーマー容器(株式会社吉野工業所製)に充填した。
 専門パネル3名が、両手を水で濡らし、一度両手を振って水気を軽くとった右手の平に、実施例1~32及び比較例1~12の各皮膚洗浄剤組成物1g(1プッシュ)を25℃の条件において、フォーマー容器から吐出させた。両手の手の平を合わせて往復させるように手の平を擦り、両手を10秒間擦りあわせた後、水道水(25℃、2L/分間)で両手をすすぎ、タオルドライ後、「手肌への刺激のなさ」を下記評価基準に基づき評価した。結果は、専門パネル3名の平均評価点を求め、下記判定基準に基づき判定した。
-「手肌への刺激のなさ」の評価基準-
 5 : 洗浄中また乾燥した時に、手肌に刺激が全くない
 4 : 洗浄中また乾燥した時に、手肌に刺激がほとんどない
 3 : 洗浄中または乾燥した時に、手肌に刺激がわずかにある
 2 : 洗浄中または乾燥した時に、手肌に刺激がある
 1 : 洗浄中または乾燥した時に、手肌に強い刺激がある
-「手肌への刺激のなさ」の判定基準-
 ◎ : 平均評価点が4.0以上
 〇 : 平均評価点が3.0以上4.0未満
 △ : 平均評価点が2.0以上3.0未満
 × : 平均評価点が2.0未満
<Lack of stimulation to hand skin>
Each skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 12 was filled in a foamer container (manufactured by Yoshino Kogyosho Co., Ltd.).
Three expert panelists wet both hands with water and shake them once to lightly dry them. It was discharged from the former container under the condition of 25°C. Rub the palms of both hands in a reciprocating motion, rub the palms together for 10 seconds, rinse both hands with tap water (25 ° C, 2 L / min), dry with a towel, ” was evaluated based on the following evaluation criteria. The results were evaluated based on the following evaluation criteria by calculating the average score of 3 expert panelists.
-Evaluation Criteria for “Lack of Irritation to Hand Skin”-
5: No skin irritation during washing and drying 4: Little irritation during washing and drying 3: Slight irritation during washing and drying 2 : Irritation to hand skin during washing or drying 1 : Strong irritation to hand skin during washing or drying - Criteria for “no irritation to hand skin” -
◎: Average score is 4.0 or more ○: Average score is 3.0 or more and less than 4.0 △: Average score is 2.0 or more and less than 3.0 ×: Average score is less than 2.0

<安定性>
 実施例1~32及び比較例1~12の各皮膚洗浄剤組成物の(1)「低温安定性」、(2)「高温安定性」、及び(3)「pH」を以下の方法で評価し、(1)~(3)のそれぞれの項目の合計点を求め、下記判定基準に基づき「安定性」を判定した。
-「安定性」の判定基準-
 ◎ : (1)~(3)の合計点が12.0点以上、かつ(1)~(3)の全項目が3点以上
 ○ : (1)~(3)の合計点が9.0点以上12.0点未満、かつ(1)~(3)の全項目が3点以上
 △ : (1)~(3)の合計点が6.0点以上9.0点未満、かつ(1)~(3)の全項目が2点以上
 × : (1)~(3)の合計点が6.0点未満
<Stability>
(1) “low temperature stability”, (2) “high temperature stability”, and (3) “pH” of each skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 12 were evaluated by the following methods. Then, the total score for each of the items (1) to (3) was obtained, and the “stability” was determined based on the following criteria.
- Criteria for “stability” -
◎: The total score of (1) to (3) is 12.0 points or more, and all items (1) to (3) are 3 points or more ○: The total score of (1) to (3) is 9.0 points points or more and less than 12.0 points, and all items (1) to (3) are 3 points or more △: The total points of (1) to (3) are 6.0 points or more and less than 9.0 points, and (1 ) to (3) all items are 2 points or more × : Total score of (1) to (3) is less than 6.0 points

(1)低温安定性
 実施例1~32及び比較例1~12の各皮膚洗浄剤組成物50gを硬質ガラスのバイアル瓶に充填し、10℃の環境下で1ヶ月間保管した後又は10℃の環境下で1ヶ月間保管後に25℃に戻した後、専門パネル1名が液外観を目視にて観察し、下記評価基準に基づき「低温安定性」を評価した。
-「低温安定性」の評価基準-
 5点 : 10℃で1ヵ月保管後に析出が全くない
 4点 : 10℃で1ヵ月保管後に25℃に戻した際に析出物がない
 3点 : 10℃で1ヵ月保管後に25℃に戻した際にわずかに析出物による懸濁が認められる
 2点 : 10℃で1ヵ月保管後に25℃に戻した際に析出物が認められる
 1点 : 10℃で1ヵ月保管後に25℃に戻した際に多量の析出物が認められる
(1) Low-temperature stability After filling 50 g of each skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 12 into a hard glass vial bottle and storing the composition at 10°C for 1 month, or at 10°C. After being stored for 1 month under the environment of , the temperature was returned to 25° C., and then one expert panel visually observed the appearance of the liquid and evaluated the “low temperature stability” based on the following evaluation criteria.
-Evaluation Criteria for “Low Temperature Stability”-
5 points: No precipitation after storage at 10°C for 1 month 4 points: No precipitation after storage at 10°C for 1 month and then returned to 25°C 3 points: Returned to 25°C after storage at 10°C for 1 month 2 points: precipitates are observed when the temperature is returned to 25°C after storage at 10°C for 1 month. 1 point: when the temperature is returned to 25°C after storage at 10°C for 1 month. A large amount of precipitates are observed in

(2)高温安定性
 実施例1~32及び比較例1~12の各皮膚洗浄剤組成物50gを硬質ガラスのバイアル瓶に充填し、50℃の環境下で1ヶ月間保管した後、専門パネル1名が液外観目視観察及び臭気評価をし、下記評価基準に基づき「高温安定性」を評価した。
-「高温安定性」の評価基準-
 5点 : 50℃で1ヵ月保管後に保存前と比較して色及び臭いに変化がない
 4点 : 50℃で1ヵ月保管後に保存前と比較して色及び臭いにほとんど変化がない
 3点 : 50℃で1ヵ月保管後に保存前と比較して色又は臭いにわずかに変化が認められるが、商品価値上問題がない程度である
 2点 : 50℃で1ヵ月保管後に保存前と比較して色又は臭いに変化が認められ、商品価値上問題がある
 1点 : 50℃で1ヵ月保管後に保存前と比較して色又は臭いが大きく変化し、商品価値上問題がある
(2) High Temperature Stability 50 g of each skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 12 was filled into a hard glass vial and stored in an environment of 50° C. for 1 month. One person visually observed the liquid appearance and evaluated the odor, and evaluated the "high-temperature stability" based on the following evaluation criteria.
-Evaluation Criteria for “High Temperature Stability”-
5 points: After storage at 50°C for 1 month, there is no change in color and odor compared to before storage 4 points: After storage at 50°C for 1 month, there is almost no change in color and odor compared to before storage 3 points: After storage at 50°C for 1 month, a slight change in color or odor is observed compared to before storage, but there is no problem in terms of commercial value. 2 points: Compared to before storage after storage at 50°C for 1 month A change in color or odor is observed, and there is a problem in terms of commercial value. 1 point: After storage at 50°C for one month, the color or odor changes significantly compared to before storage, and there is a problem in terms of commercial value.

(3)pH
 実施例1~32及び比較例1~12の各皮膚洗浄剤組成物50gを硬質ガラスのバイアル瓶に充填し、50℃の環境下で1ヶ月間保管した後、pHメーター(東亜ディーケーケー株式会社製、HM-30V)を用いてpHを測定し、下記評価基準に基づき「pH」を評価した。
-「pH」の評価基準-
 5点 : 50℃で1ヵ月保管後に保存前と比較してpH変化が±0.2以内
 4点 : 50℃で1ヵ月保管後に保存前と比較してpH変化が±0.2超え±0.4以内
 3点 : 50℃で1ヵ月保管後に保存前と比較してpH変化が±0.4超え±0.6以内
 2点 : 50℃で1ヵ月保管後に保存前と比較してpH変化が±0.6超え±0.8以内
 1点 : 50℃で1ヵ月保管後に保存前と比較してpH変化が±0.8超え
(3) pH
50 g of each skin cleanser composition of Examples 1 to 32 and Comparative Examples 1 to 12 was filled in a hard glass vial bottle, stored in an environment of 50 ° C. for 1 month, and measured with a pH meter (manufactured by Toa DKK Corporation). , HM-30V), and "pH" was evaluated based on the following evaluation criteria.
-Evaluation criteria for "pH"-
5 points: pH change within ±0.2 after storage at 50°C for 1 month compared to before storage 4 points: pH change exceeds ±0.2 compared to before storage after storage at 50°C for 1 month ±0 Within .4 3 points: pH change after storage at 50°C for 1 month compared to before storage exceeds ±0.4 within ±0.6 2 points: pH change after storage at 50°C for 1 month compared to before storage is more than ±0.6 and within ±0.8 1 point: After storage at 50°C for 1 month, pH change exceeds ±0.8 compared to before storage

<表皮ブドウ球菌に対する殺菌力>
 表皮ブドウ球菌は、バリア機能をもつ皮膚の常在菌であるため、皮膚洗浄剤組成物は表皮ブドウ球菌に対する殺菌力が低いことが好ましい。そこで、以下の方法で、実施例1~32の各皮膚洗浄剤組成物の表皮ブドウ球菌に対する殺菌力を評価した。
<Bactericidal activity against Staphylococcus epidermidis>
Since Staphylococcus epidermidis is a resident bacterium of the skin that has a barrier function, the skin cleanser composition preferably has low bactericidal activity against Staphylococcus epidermidis. Therefore, the bactericidal activity against Staphylococcus epidermidis of each of the skin cleansing compositions of Examples 1 to 32 was evaluated by the following method.

(1)菌液の調製
 表皮ブドウ球菌(Staphylococcus epidermidis ATCC12228、独立行政法人製品評価技術基盤機構(NBRC)より入手)を、SCDLP培地(日本製薬株式会社製)を用いて、好気条件下で30℃にて24時間静置培養した。次に、前記表皮ブドウ球菌を生理食塩水(大塚製薬株式会社製)に懸濁させ、初発菌数が10細胞個/mLとなるように調整し、菌液を調製した。
(1) Preparation of fungal solution Staphylococcus epidermidis ( Staphylococcus epidermidis ATCC12228, obtained from the National Institute of Technology and Evaluation (NBRC)) was treated with SCDLP medium (manufactured by Nihon Pharmaceutical Co., Ltd.) under aerobic conditions for 30 minutes. It was statically cultured at ℃ for 24 hours. Next, the above-mentioned Staphylococcus epidermidis was suspended in physiological saline (manufactured by Otsuka Pharmaceutical Co., Ltd.), and the number of initial bacteria was adjusted to 10 6 cells/mL to prepare a bacterial solution.

(2)試験液の調製
 実施例1~32の各皮膚洗浄剤組成物を滅菌水で10倍希釈し、各試験液を調製した。
(2) Preparation of Test Solution Each skin cleanser composition of Examples 1 to 32 was diluted 10-fold with sterilized water to prepare each test solution.

(3)評価方法
 25℃にて、前記(2)で得られた各試験液10mLに、前記(1)で得られた菌液0.1mLを添加して十分撹拌し、前記(1)の添加から30秒間後に混合液0.3mLを取り出し、2.7mLのSCDLP寒天培地(Soybean-Casein Digest Broth with Lectin & Polysorbate 80、和光純薬工業株式会社製)に加え、10倍希釈液を得た。同様の方法を繰り返し、菌液の10倍、10倍、及び10倍の各希釈液を得た。各希釈液から1.0mLをシャーレに採取し、SCDLP寒天培地15mLを加えて均一化し、30℃にて2日間培養した後、コロニー数をカウントして生存菌数を測定した(寒天平板希釈法)。下記式(2)により初発菌数と前記生存菌数との差(Δlog10)を算出し、下記判定基準に基づき「表皮ブドウ球菌に対する殺菌力」を判定した。なお、下記式(2)により算出される数値が大きいほど殺菌力が高いことを表す。
  殺菌数Δlog10=-log10(生存菌数/初発菌数) ・・・式(2)
-「表皮ブドウ球菌に対する殺菌力」の判定基準-
 ◎ : Δlog10が、1.0未満
 ○ : Δlog10が、1.0以上2.0未満
 △ : Δlog10が、2.0以上3.0未満
 × : Δlog10が、3.0以上
(3) Evaluation method At 25 ° C., 0.1 mL of the bacterial solution obtained in (1) was added to 10 mL of each test solution obtained in (2) above, and the mixture was sufficiently stirred. 30 seconds after the addition, 0.3 mL of the mixed solution was taken out and added to 2.7 mL of SCDLP agar medium (Soybean-Casein Digest Broth with Lectin & Polysorbate 80, manufactured by Wako Pure Chemical Industries, Ltd.) to obtain a 10-fold diluted solution. . A similar method was repeated to obtain 10 2 -fold, 10 3 -fold, and 10 4 -fold dilutions of the bacterial solution. 1.0 mL of each diluted solution was collected in a petri dish, homogenized by adding 15 mL of SCDLP agar medium, and cultured at 30 ° C. for 2 days, and the number of surviving bacteria was measured by counting the number of colonies (agar plate dilution method ). The difference (Δlog 10 ) between the number of initial bacteria and the number of surviving bacteria was calculated by the following formula (2), and the "bactericidal activity against Staphylococcus epidermidis" was determined based on the criteria below. In addition, it represents that the larger the numerical value calculated by the following formula (2), the higher the bactericidal activity.
Sterilization number Δlog 10 =-log 10 (number of surviving bacteria/number of initial bacteria) Equation (2)
- Criteria for "Bactericidal activity against Staphylococcus epidermidis" -
◎: Δlog 10 is less than 1.0 ○: Δlog 10 is 1.0 or more and less than 2.0 △: Δlog 10 is 2.0 or more and less than 3.0 ×: Δlog 10 is 3.0 or more

Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004

Figure JPOXMLDOC01-appb-T000005
Figure JPOXMLDOC01-appb-T000005

Figure JPOXMLDOC01-appb-T000006
Figure JPOXMLDOC01-appb-T000006

Figure JPOXMLDOC01-appb-T000007
Figure JPOXMLDOC01-appb-T000007

Figure JPOXMLDOC01-appb-T000008
Figure JPOXMLDOC01-appb-T000008

Figure JPOXMLDOC01-appb-T000009
Figure JPOXMLDOC01-appb-T000009

(処方例1~12)
<皮膚洗浄剤組成物の調製>
 実施例1~32及び比較例1~12の皮膚洗浄剤組成物の調製において、下記表7及び表8に示す組成及び含有量(質量%)に変更したこと以外は、実施例1~32及び比較例1~12の皮膚洗浄剤組成物の調製と同様の方法で処方例1~12の皮膚洗浄剤組成物を得た。
(Prescription Examples 1-12)
<Preparation of skin cleanser composition>
In the preparation of the skin cleanser compositions of Examples 1 to 32 and Comparative Examples 1 to 12, except that the compositions and contents (mass%) shown in Tables 7 and 8 below were changed, Examples 1 to 32 and Skin cleansing compositions of Formulation Examples 1-12 were obtained in the same manner as the preparation of the skin cleansing compositions of Comparative Examples 1-12.

Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000010

Figure JPOXMLDOC01-appb-T000011
Figure JPOXMLDOC01-appb-T000011

 実施例1~32、比較例1~12、又は処方例1~12で使用した各成分の詳細について、下記表9に示す。 The details of each component used in Examples 1-32, Comparative Examples 1-12, or Formulation Examples 1-12 are shown in Table 9 below.

Figure JPOXMLDOC01-appb-T000012
 ※1:ラウリン酸カリウムは、ラウリン酸(Kortacid 1299、Pacific Oleochemicals製)を水酸化カリウム(POTASSIUM HYDROXIDE 48%、UNID製)で中和させて調製したものを使用した。
 ※2:ミリスチン酸カリウムは、ミリスチン酸(Kortacid 1499、Pacific Oleochemicals製)を水酸化カリウム(POTASSIUM HYDROXIDE 48%、UNID製)で中和させて調製したものを使用した。
Figure JPOXMLDOC01-appb-T000012
*1: Potassium laurate was prepared by neutralizing lauric acid (Kortacid 1299, manufactured by Pacific Oleochemicals) with potassium hydroxide (POTASSIUM HYDROXIDE 48%, manufactured by UNID).
*2: Potassium myristate was prepared by neutralizing myristic acid (Kortacid 1499, manufactured by Pacific Oleochemicals) with potassium hydroxide (POTASSIUM HYDROXIDE 48%, manufactured by UNID).

 前記皮膚洗浄剤組成物は、皮膚上のバリア機能を高める常在菌は保持しながら、病原性を持つ大腸菌等に対しては高い殺菌力を有し、着色がなく液外観が良好であり、嫌味臭がなく、泡質、洗浄後の感触、手肌への刺激のなさ、及び安定性に優れるため、例えば、ボディシャンプー、ボディソープ、洗顔フォーム、液体ハンドソープ、泡ハンドソープ、クレンジングフォーム、メイク落としなどに用いることができ、特に泡状で吐出される液体ハンドソープに好適に用いることができる。 The skin cleanser composition retains the indigenous bacteria that enhance the barrier function on the skin, has high bactericidal activity against pathogenic E. coli and the like, and has a good liquid appearance without coloration. It has no unpleasant odor, excellent foam quality, feel after washing, no irritation to hands and skin, and excellent stability. It can be used for makeup removal and the like, and can be particularly suitably used for liquid hand soap that is discharged in foam form.

Claims (5)

 (A)アニオン性界面活性剤と、
 (B)チシマザサ抽出物及びハッカの水抽出物から選択される少なくとも1種の植物抽出物と、
 (C)グリセリン、1,3-ブチレングリコール、及びプロピレングリコールから選択される少なくとも1種の多価アルコールと、
を含有し、前記(B)成分の含有量に対する前記(C)成分の含有量の質量比[(C)/(B)]が3~30であることを特徴とする皮膚洗浄剤組成物。
(A) an anionic surfactant;
(B) at least one plant extract selected from extracts of Sasa squamosa and water extracts of mint;
(C) at least one polyhydric alcohol selected from glycerin, 1,3-butylene glycol, and propylene glycol;
and wherein the mass ratio [(C)/(B)] of the content of component (C) to the content of component (B) is 3-30.
 (B)成分のチシマザサ抽出物がチシマザサ水であり、(B)成分のハッカの水抽出物がハッカ油である請求項1に記載の皮膚洗浄剤組成物。 The skin cleanser composition according to Claim 1, wherein the extract of component (B) is Sasa serrata water, and the water extract of mint (B) is mint oil.  (A)成分の含有量が、5質量%~12質量%であり、
 (B)成分のチシマザサ抽出物の含有量が、0.5質量%~1.2質量%であり、(B)成分のハッカの水抽出物の含有量が、0.2質量%~0.5質量%であり、
 (C)成分が、5質量%~10質量%である請求項1から2のいずれかに記載の皮膚洗浄剤組成物。
The content of component (A) is 5% by mass to 12% by mass,
The content of the extract of component (B) is 0.5% by mass to 1.2% by mass, and the content of the water extract of component (B) is 0.2% by mass to 0.2% by mass. 5% by mass,
3. The skin cleanser composition according to claim 1, wherein component (C) is 5% by mass to 10% by mass.
 (D)両性界面活性剤を更に含有する請求項1から3のいずれかに記載の皮膚洗浄剤組成物。 (D) The skin cleanser composition according to any one of claims 1 to 3, further comprising an amphoteric surfactant.  (D)成分の含有量が、0.5質量%~4質量%である請求項4に記載の皮膚洗浄剤組成物。 The skin cleanser composition according to claim 4, wherein the content of component (D) is 0.5% by mass to 4% by mass.
PCT/JP2022/003997 2021-03-02 2022-02-02 Skin cleaning agent composition Ceased WO2022185819A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020237024696A KR20230149289A (en) 2021-03-02 2022-02-02 Skin Cleanser Composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021032588A JP7736408B2 (en) 2021-03-02 2021-03-02 Liquid skin cleanser composition
JP2021-032588 2021-03-02

Publications (1)

Publication Number Publication Date
WO2022185819A1 true WO2022185819A1 (en) 2022-09-09

Family

ID=83155015

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/003997 Ceased WO2022185819A1 (en) 2021-03-02 2022-02-02 Skin cleaning agent composition

Country Status (3)

Country Link
JP (1) JP7736408B2 (en)
KR (1) KR20230149289A (en)
WO (1) WO2022185819A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008018118A1 (en) * 2006-08-07 2008-02-14 Noevir Co., Ltd. Composition containing nemagaritake and moisturizing agent, cellular stimulant, whitening agent and antioxidant
JP2011225477A (en) * 2010-04-19 2011-11-10 Noevir Co Ltd Anti-aging agent, antioxidant, external preparation for skin, and functional oral composition
JP2012240944A (en) * 2011-05-18 2012-12-10 Kuroisutaazu :Kk Skin care preparation
JP2019089737A (en) * 2017-11-16 2019-06-13 株式会社マンダム Bar soap

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4812298B2 (en) 2004-12-27 2011-11-09 ライオン株式会社 Hand cleaning composition
MY188924A (en) 2009-10-06 2022-01-13 Lion Corp Liquid skin cleanser composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008018118A1 (en) * 2006-08-07 2008-02-14 Noevir Co., Ltd. Composition containing nemagaritake and moisturizing agent, cellular stimulant, whitening agent and antioxidant
JP2011225477A (en) * 2010-04-19 2011-11-10 Noevir Co Ltd Anti-aging agent, antioxidant, external preparation for skin, and functional oral composition
JP2012240944A (en) * 2011-05-18 2012-12-10 Kuroisutaazu :Kk Skin care preparation
JP2019089737A (en) * 2017-11-16 2019-06-13 株式会社マンダム Bar soap

Also Published As

Publication number Publication date
JP7736408B2 (en) 2025-09-09
JP2022133728A (en) 2022-09-14
KR20230149289A (en) 2023-10-26

Similar Documents

Publication Publication Date Title
JP6183849B2 (en) Skin cleanser composition
JP6362496B2 (en) Cellulose nanofiber aqueous dispersion composition, food and cosmetics using the same.
CN101896595B (en) Bactericidal cleanser composition
WO2017199921A1 (en) Antibacterial composition, and cosmetic composition and sheet-type product for skin comprising same
BR112014026091B1 (en) foaming formulations, preparation process, and method for body cleansing
JP6694343B2 (en) Skin cleanser composition
JP2011074082A (en) Antiseptic sterilizer and composition for application to human body
JP6134837B1 (en) Liquid detergent composition
JP6062279B2 (en) Liquid detergent composition
CN106109259B (en) A kind of shampoo shower cream preventing stink with perspiration
JP2017171625A (en) Cleaning composition
JP2014156538A (en) Liquid detergent composition
JP2003096494A (en) Weakly acidic detergent composition
JP6990496B2 (en) Detergent composition
JP7431069B2 (en) Liquid cleaning agent for filling former containers
JP2016094375A (en) Liquid detergent composition for former container
JP4734293B2 (en) Antiseptic disinfectant and human body composition
JP2014129244A (en) Skin cleanser composition
JP7736408B2 (en) Liquid skin cleanser composition
JP7217925B2 (en) skin cleanser composition
US12076427B2 (en) Compositions having low sulfate containing surfactants
EP4126252B1 (en) Compositions comprising naturally derived preservatives
JP2022049814A (en) Moist feeling-enhancing agent and detergent composition
JP2025065680A (en) Skin cleansing composition
KR101616251B1 (en) Composite for Shampoo with High Bubble Generation Capability

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22762877

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22762877

Country of ref document: EP

Kind code of ref document: A1